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A three-dimensional display is a useful method which can provide spatially accurate
representations of high-resolution images with a 360° view. Therefore, it has potential to be applied
widely in the medical area, entertainment industry and for military applications. According to the
first-generation 3D digital light photoactivatable dye display (3D Light PAD), N-phenyl
spirolactam rhodamine B was used as photoactivatable compound that could be switched from
non-fluorescent to fluorescent using ultraviolet light. However, the detailed mechanism, how other
rhodamine derivatives would perform in 3D Light PAD, and what other factors in this system
could improve the imaging quality remained unclear. In order to solve these problems and
understand the properties of rhodamine derivatives, we synthesized a series of N-aryl spirolactam
rhodamine photoswitches and tested their spectroscopic characterizations such as irradiation
wavelength and absorbance, duration of switching from off-state to on-state and irradiation
wavelength dependence. Also, extinction coefficients and fluorescent quantum yields of the
fluorescent form of these compounds was measured by using trifluoroacetic acid to drive the
equilibrium to the open form. According to these results, N-aryl spirolactam rhodamine derivatives
with fluorinated aminoalkyl groups (SRCF3) that have green (518 nm) emission wavelengths were
vi

synthesized by a new procedure and their spectroscopic characterizations including extinction
coefficients and fluorescent quantum yields were measured by the same methods as the red dyes.
These results helped us better understand the mechanism of photoswithching reactions more
clearly and were used to set the foundation for a multi-color volumetric 3D display.
Different with fluorescence, chemiluminescence is the light production from exothermic chemical
reactions, where the excited state is accessed during the reaction and then the light will be
generated by relaxation from excited state to the ground state. As an imaging modality,
chemiluminescence has many advantages compared with current imaging methods, including
fluorescence,

bioluminescence

and

phosphorescence.

The

most

important

thing

is

chemiluminescence could work well both in vivo and in vitro without light excitation or genetic
modification like fluorescence and bioluminescence. Based on it, several chemiluminescent probes
for different reactive species were designed, synthesized, characterized, and applied for cellular
and in vivo studies. CHS-4 and CL-DNP are chemiluminescent probes for hydrogen sulfide (H2S)
with azide and dinitro phenyl group triggers. According to the sensitivity and selectivity studies of
these probes during in vitro tests, finally the cellular studies of them were designed in A549 cells.
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CHAPTER 1
SPIROLACTAM RHODAMINE PHOTOSWITCHES FOR VOLUMETRIC 3D DISPLAYS

1.1 Introduction
1.1.1 Spirolactam rhodamine photoswitches
Photoswitches are a series of molecules which can achieve reversible photoactivation
processes by chemical reactions.1 Based on the properties of these molecules, many applications
such as molecular machines,2 3D printing,3 advanced materials4 have been explored in the last
decades. With more research in this area, there are various classes of photoswitches being
developed, including azobenzenes,5 diarylethenes,6 oxazines,7 acyl hydrazones,8 spiropyrans,9
dihydropyrenes10 and spirolactam rhodamines11 and the mechanism of photoactivation is
becoming more clearly understood.
As representative fluorescent photoswitches, spirolactam rhodamines can be used for
numerous applications like single-molecule microscopy12 and volumetric 3D digital light
photoactivatable dye displays.13,14 These applications depend on the mechanisms of
photoactivation process as described in Scheme 1-1. Spirolactam rhodamines could be
transformed from a non-fluorescent state into a fluorescent state with a specific wavelength of
light irradiation. Not only this fluorescent state can be excited to the emissive excited state by
illumination but also the on-state molecule could achieve relaxation to the non-fluorescent state
by a thermal fading process.
1

Scheme 1-1. Mechanism of single molecule photoactivation. (Adapted with permission from
reference 17. Copyright 2009 John Wiley and Sons)

1.1.2 Volumetric 3D display
As a novel and useful technology, volumetric 3D displays can be used in various applications,
such as medical imaging, engineering, education, and other areas, which exists everywhere in
our daily life.15,16 Compared with traditional 2D imaging, volumetric 3D displays can show the
real structure in specific condition and the detailed differences of some physical factors, like the
eyes’ activities17, motion parallax18 and binocular disparity19. In addition, volumetric 3D displays
can be characterized not only into swept-volume displays,20 such as high-speed scanning and
rotating light imaging,21,22,23,24 but also static volume displays25 like active matrix displays26 and
beam-addressable displays.27,28,29
A chemically enabled volumetric 3D digital light photoactivatable dye display (3D Light PAD)
is an effective method for 3D image generation.30,31 (Figure 1-1) There are two important factors
in this system, one is a special class of photoactivatable molecules, the other is digital light
processing (DLP) technology to generate structured light in three dimensions. Spirolactam
rhodamine photoswitches are specific molecules that have found widespread use in volumetric
3D displays. DLP projector technology consists of two personal computers which control a
2

Miroir 720p picoprojector, and a Pro4500 projector equipped with a 385 nm ultraviolet LED and
a 525 nm green LED.32 The ultraviolet light is used to complete the photoactivation and green
LED is used to project a 2D visible light with ultraviolet pattern projected from the Pro4500.
Finally, high-resolution images were displayed from both Pro4500 projector and green LED to
generate 3D image at the intersection. (Figure 1-2)

Figure 1-1. Digital light processing (DLP) for volumetric 3D display. (Adapted with permission
from reference 32. Copyright 2017 Nature communication)

O
NR
N

O

N

Figure 1-2. High-resolution images generation by DLP system. (Adapted with permission from
reference 32. Copyright 2017 Nature communication)
3

1.1.3 Photoswitching kinetics
As a specific class of photoswitches, the photoswitching mechanisms of spirolactam
rhodamine derivatives has been investigated in past years. As the Figure 1-3 shows, spirolactam
rhodamine has a colorless and non-fluorescent closed form in DCM solvent33 which could
achieve a photochemical reaction that switch the close-form molecule into an open fluorescent
form.34 According to this, Gleiter group made more research about the kinetics of this
photoactivation process and thermal fading in other solvents such as water and alcohols.35
Besides that, Bossi developed another experiment that demonstrated the kinetics of isomerization
and acid induced changes with addition of trifluoroacetic acid for N-phenyl spirolactam
rhodamine photoswitches.36 After that, they set up a four-state mechanism that described this
photoswitching process with a first order reaction model.37 Scott et.al explored the aciddependent properties of these derivatives based on the previous results,38,39 that were valuable
for us. In the summary, these studies provided us with more kinetics and synthetic methodology
knowledge of spirolactam rhodamine photoswitches and spectroscopy measurements of this
series of derivatives,43,44 for example absorption and emission intensity, photoswitching
kinetics45 and quantum yields46 are useful for us to make more comprehensive understanding of
the mechanisms of photoactivation.
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Figure 1-3. Photoactivation process of spirolactam rhodamine photoswitches. (Adapted with
permission from reference 32. Copyright 2017 Nature communication)

1.2 Research objectives
In our previous work, we used N-phenyl spirolactam rhodamine B as a fluorescent photoswitch
to generate 3D images in a solution of dichloromethane in a 3D display31. According to this
result, we design and synthesize various of photoswitches with different colors, spirolactam
rhodamine B (SRB) with red emission wavelengths (585 nm) and spirolactam rhodamine
derivatives with fluorinated aminoalkyl groups (SRCF3) with green emission wavelengths (518
nm). In this project, we developed a new procedure to prepare fluorinated spirolactam rhodamine
derivatives. Additionally, we completed spectroscopy measurements for these compounds such
as absorption and emission spectrum, as well as excitation time scanning. Furthermore, we
measured the kinetics and quantum yields of every fluorescent derivative, which is useful for us
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to understand the photoactivation mechanisms and achieve multi-color 3D display by DLP
technology in the future.

1.3 Results and discussions
1.3.1 Design and synthesis of spirolactam rhodamine B (SRB) and fluorinated spirolactam
rhodamine (SRCF3) derivatives
In our project, we synthesized nine spirolactam rhodamine B (SRB) derivates (red dye) and
eight fluorinated spirolactam rhodamine (SRCF3) derivatives (green dye). The SRB derivatives
were synthesized by rhodamine B coupling with a library of anilines in phosphorus oxychloride
condition. Derivatives were designed with electron donating groups (compounds 2, 3, 7–9),
electron withdrawing groups (compounds 4–6), and steric hindrance photoswitches (compounds
7–9). The SRCF3 compounds were synthesized starting from fluorescein and the bis-triflate was
prepared with high yield. The final precursor product was produced by palladium catalysis with
the XPhos for generating the fluorinated rhodamine with trifluoro ethyl-amino groups. In the
next step, we prepared derivatives with similar method as SRB derivatives, which reacted with
electron donating groups (compounds 12–16), electron withdrawing groups (compounds 11, 17),
and sterically-hindered groups (compounds 12, 13, 16).
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Scheme 1-2. Synthesis of SRB derivatives (red dye). (Adapted with permission from reference
17. Copyright 2009 John Wiley and Sons)

7

Scheme 1-3. Synthesis of SRCF3 derivatives (green dye). (Adapted with permission from
reference 45. Copyright 2021 Elesvier)

1.3.2 Tuning and photophysical properties experiments
According to the absorption and emission spectrum results, we first measured the extinction
coefficients (556nm(on), 495nm(on)) and fluorescence quantum yields (fl) of the fluorescent state of
the dyes that could describe how strongly a species absorbs radiation or light at a particular
wavelength. According to some studies about visible-light photoswitching and acid-catalyzed
isomerization, the researchers found that TFA addition could provide the proton combining with
the nitrogen of N-aryl group for achieving the intermolecular proton transfer of photoswitching
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derivatives which could complete similar photoactivation process with UV light irradiation.47,48
Based on it, we attempted to add trifluoroacetic acid with different equivalents for achieving the
complete conversion for them to the on-state. As the results show, fully turn-on state happened
with the addition of 50 equivalents of trifluoroacetic acid for the SRB derivatives and 500
equivalents of trifluoroacetic acid for SRCF3 derivatives. (Figure 1-4) Then we obtained
extinction coefficients at 556 nm for SRB compounds (Figure 1-5) and at 495 nm for SRCF3
compounds (Figure 1-6). As these results, 556nm(on) were found to be between 84,700 M-1 cm-1
and 132,100 M-1 cm-1 for the SRB series (Table 1-1) and 495nm(on) were found to be between
54,400 M-1 cm-1 and 94,900 M-1 cm-1 for SRCF3 series (Table 1-2).
Similarly, the fluorescence quantum yields (fl) measurements were also determined by
trifluoracetic acid addition to drive the equilibrium to the complete fluorescent state. Finally, we
found that derivatives with electron-rich aryl groups (compounds 2, 3, 7, 13–15) had lower
quantum yields. The reason of this result was probably because donating group could enhance
the efficiency of photoinduced electron transferring (PET) in fluorescence quenching, which
leaded to decrease the slope values for calibration curve of absorption verse fluorescence
emission. Furthermore, the other derivatives with high steric hindrance (compounds 8, 9, 12, 16)
performed similar fluorescence quantum yields with original product.
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Figure 1-4. TFA addition experiments. (A) Fluorescence emission intensity at 585 nm of 5 µM 1
incubated with 50 equivalents of TFA for 0–60 min. (B) Fluorescence emission intensity at 585
nm of 5 µM 1 with 0–100 equivalents of TFA after incubating for 40 min. (C) Fluorescence
emission intensity at 518 nm of 5 µM 10 incubated with 500 equivalents of TFA for 0–60 min.
(D) Fluorescence emission intensity at 518 nm of 5 µM 10 with 0–1000 equivalents of TFA after
incubating for 40 min. Indicate permissions – these figures are in the SI, so it is still safer to
indicate the permissions. (Adapted with permission from reference 45. Copyright 2021 Elesvier)
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Figure 1-5. Extinction coefficient linear fits of absorbance at 556 nm versus concentration of
compounds 1–9. (Adapted with permission from reference 45. Copyright 2021 Elesvier)

Figure 1-6. Extinction coefficient linear fits of absorbance at 495 nm versus concentration of
compounds 10–17. (Adapted with permission from reference 45. Copyright 2021 Elesvier)
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Compound

fl / %

1

52

556nm(on)
84,700

2

5

122,400

3

16

110,200

4

36

96,000

5

24

118,900

6

55

132,100

7

15

117,500

8

28

103,500

9

33

112,200

Table 1-1. Fluorescence quantum yields and extinction coefficients of the on-state of N-aryl
spirolactam rhodamine B (SRB) derivatives in dichloromethane.

Compound

fl / %

495nm(on)

10

58

94,900

11

24

91,400

12

41

94,200

13

6

90,900

14

3

65,900

15

1

58,900

16

31

70,300

17

13

54,400

Table 1-2. Fluorescence quantum yields and extinction coefficients of the on-state of fluorinated
N-aryl spirolactam rhodamine (SRCF3) derivatives in dichloromethane.

Besides the extinction coefficient and fluorescence quantum yields, we determined the on-rates
(kon) and photochemical quantum yields (pc) of the photoswitching reactions which quantify the
relationship between reaction rate and light quantity. Both of these two characterizations are
related by equation 3 (All equations are showed in Methods sections 1.4.3 and Figure 1-8A) and
12

depend on the extinction coefficients of the closed form (254nm(off)) (Figure 1-7). and the
excitation light intensity (I0). We measured the maximum fluorescence emission intensity of the
open form with continuous excitation at 254 nm and then fit this data to the rate equation for a
reaction at equilibrium. For confirming the robust of results, we choose two methods of
photochemical quantum yields measurement. First, we measured N-phenyl spirolactam
rhodamine B (compound 1) emission spectrum and found that its fluorescence emission at 585
nm with continuous excitation at 254 nm provided a smooth time-scan curve and finally reached
an equilibrium state after about 1200 seconds (Figure 1-8A).
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Figure 1-7. Extinction coefficient linear fits of absorbance at 254 nm versus concentration of
compounds 1–17. (Adapted with permission from reference 45. Copyright 2021 Elesvier)

We fitted this data with equation 3 using Mathematica software and the rate constants were
determined as kon = 1.53 x 10–3 s–1, koff = 1.14 x 10–3 s–1 after fitting. (Figure 1-8B) The
equilibrium constant Keq was determined directly by using kon and koff values, which described
the photoactivation process in more detail and demonstrated the reaction trends and speed of this
mechanisms for every derivative. kon is the rate for the light-mediated reaction that converts the
closed form to the open form. koff is the rate for this reaction that returns to the close form. Also,
Keq is valuable for us to describe the final state at equilibrium and understand the relationship
between electron inductive groups and the kinetics. For confirming these fits result, we used
another approach to compare the equilibrium constant evaluated with this method to that
determined by obtaining the maximum emission of fluorescent state by driving the equilibrium
to the on-state with addition of trifluoracetic acid (Figure 1-9A). For example, we found that the
value of 5 µM concentration on this calibration curve performs the maximum fluorescence (Imax)
14

in the open fluorescent form in Figure 1-8A. The calibration curve of it could be used to
determine the concentration of the fluorescent state and nonfluorescent state when the
photochemical reaction reached at equilibrium, then Keq was determined with them. Comparing
the results using these two methods, the equilibrium constant determined by different approaches
is similar (Figure 1-9B).

Figure 1-8. Methodology to measure photoswitching rates (Method 1). (A) Emission intensity at
585 nm of 5 µM 1 in CH2Cl2 irradiated with 50.8 µW cm-2 of 254 nm light (black trace) and the
fit to equation 3 (red trace). (B) Equation and parameters found for the trace shown in (A).
(Adapted with permission from reference 45. Copyright 2021 Elesvier)
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Figure 1-9. Another method of photoswitching rates measurement (Method 2). (A) Calibration
curve generated from increasing concentrations of 1 in CH2Cl2 40 min after addition of 50
equivalents of TFA. Data are average values from n = 6 independent experiments. Error bars are
 S.D. (B) Comparison of Keq determined from Method 1: koff and kon found from equation 1 and
Method 2: Determined by evaluating the equilibrium concentration of the on-state using the
equilibrium fluorescence emission in (Figure 1-7A) and the calibration curve in (A). (Adapted
with permission from reference 45. Copyright 2021 Elesvier)

Next, we summarized the fluorescence turn-on data and determined photochemical quantum
yields for the series of SRB photoswitches (Table 1-3). Extinction coefficients (254nm(off)) on the
closed form were were found to be between 34,500 M-1cm-1 and 47,000 M-1cm-1 and the off-rates
koff values were determined to be in the range of 0.38–6.1 x 10–3 s–1 for these derivatives.
According to these results, we found that SRB photoswitches with electron withdrawing groups
(compounds 4–6) and the sterically hindered group compound 9 had lower values for koff
compared with compound 1. The photoswitches with electron donating groups (compounds 2, 3,
7, and 8) had similar koff values which were found to be between 0.93 x 10–3 s–1 and 6.1 x 10–3 s–
1

. As the difference of nucleophillicity for every derivatives, compound 4-6 have stronger

electron withdrawing effect to the nitrogen negative part which makes the converse from open
form to close form more difficult, that caused there are higher kon and lower koff. In the other
hand, compound 2 and 3 with electron donating groups prefer to push the photoactivation
equilibrium to the closed form and prevent the reaction switching to the fluorescent state which
leads to increase koff value.
We next evaluated the kon values for using these to determine the equilibrium constant (Keq)
and the photochemical quantum yield (pc). Althogh the 4-methoxy and 3,4-dimethoxy electronrich derivatives 2 and 3 have lower kon, pc, and Keq, the effect of electron withdrawing and
16

sterically hindered substituents on kon was not increasing obviously. Compared to the -methoxy
compounds, we found that the phenyl, 2-fluoro, 2-methyl, 2,6-dimethyl, and 2,6-diisopropyl
compounds had higher kon and pc, which indicated that steric hindrance in the spirolactam
structure would increase the turn-on rate and fluorescence quantum yield. On the other hand, the
2-fluoro, 3-chloro, and 3-fluoro derivatives performed slightly lower kon and pc values than that
of the original derivative, that indicated that the photochemical reaction rate kon is not completely
influenced by the electronic inductive effect of the N-aryl substituent. Compared with SRB
derivatives, the green dye SRCF3 photoswitches had much higher koff value compared with the
SRB derivatives for the same measurement (Table 1-4). This result demonstrated that the
fluorination of the amino groups prefer to pushing the equilibrium forward to the closed form of
the dye. Also this effect could be affected strongly by electron-withdrawing groups (compound
11 and 17) or steric hinderance at the spirolactam position (compounds 12, 13, 16), which
performed much lower koff values compared with the original N-phenyl compound.
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Compound

254nm(off)

1

40,300

2

42,600

3

41,800

4

40,400

5

47,000

6

42,300

7

41,300

8

34,500

9

38,900

Keq
1.36
0.05
0.044
0.023
0.17
0.056
1.54
0.12
1.23
0.15
1.93
0.62
1.64
0.13
0.68
0.14
1.37
0.46

koff[a]
1.2
0.3
6.1
3.5
1.4
0.44
0.72
0.16
0.38
0.24
0.57
0.45
0.93
0.56
2.7
1.1
0.60
0.1

kon[a]
1.6
0.4
0.31
0.26
0.25
0.14
1.1
0.2
0.49
0.34
0.97
0.54
1.5
1.0
1.8
1.0
0.84
0.39

pc / %
6.0
1.5
1.1
0.93
0.82
0.45
4.1
0.83
1.6
1.1
3.1
1.8
6.7
3.7
8.0
4.2
3.3
1.5

Table 1-3. Kinetics and photochemical quantum yields of 5 µM N-aryl spirolactam Rhodamine
B (SRB) derivatives in dichloromethane.

Compound

254nm(off)

10

41,300

11

37,600

12

36,500

13

40,400

14

36,300

15

41,100

16

36,800

17

43,400

Keq
0.016
0.0011
0.28
0.051
0.75
0.038
0.094
0.064
0.0095
0.0013
0.0094
0.0023
0.78
0.10
0.069
0.0079

koff [a]
182
26
4.7
1.4
2.8
1.1
3.2
1.2
287
16
356
88
1.9
0.086
46
19

kon[a]
2.9
0.29
1.3
0.26
2.1
0.79
0.25
0.066
2.7
0.47
3.3
0.9
1.5
0.14
3.1
0.89

pc / %
11
1
5.3
1.0
8.8
3.3
0.94
0.002
11
2.0
18
5.0
6.1
0.56
11
3.1

Table 1-4. Kinetics and photochemical quantum yields of 5 µM fluorinated N-aryl spirolactam
rhodamine (SRCF3) derivatives in dichloromethane.
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1.3.3 Volumetric 3D display imaging
Finally, based on the results of the spectroscopy measurements, we attempted to choose a
proper photoswitching molecule compound 10 which has a good performance of fluorescence
quantum yields and high value of Keq, that demonstrates the probe could achieve the
photoactivation efficiently and controllably and make preliminary volumetric 3D display using
the 3D Light PAD. For optimizing the imaging system and increasing the imaging quality, we
found that the addition of triethylamine had a significant effect on the koff value, which increases
from 1.2 x 10–3 s-1 in the absence of triethylamine to 30 x 10–3 s–1 in the presence of
triethylamine. This result was useful for us to achieve the high-resolution disply with better
quality observed. Therefore, we used the 5 µM 2-fluoro SRCF3 as photoswitchable molecule in
dichloromethane with 7.2 µM triethylamine in a 2.5 cm x 2.5 cm x 5 cm cuvette and a 254 nm
excitation source for making 3D displays. A 254 nm TLC lamp was projected as UV light source
and a blue light was projected from the side using a LightCrafter 4500 projector. A green light
display can be observed (Figure 1-10B), that provide a useful demonstration for new synthetic
green dye SRCF3 photoswitches using in DLP technology.
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Figure 1-10. Demonstration of 3D Voxel Formation. (A) Schematic and (B) photograph of the
setup for 3D voxel formation using a 254 nm TLC lamp, the blue LED of a LightCrafter 4500
projector, and a cuvette filled with 5 µM 11 and 7.2 µM triethylamine. (Adapted with permission
from reference 45. Copyright 2021 Elesvier)

1.4 Experimental Section
1.4.1 General materials and methods
All reactions were performed in dried glassware under an atmosphere of dry N2. Silica gel P60
(SiliCycle) was used for column chromatography and SiliCycle 60 F254 silica gel (precoated
sheets, 0.25 mm thick) was used for analytical thin layer chromatography. Plates were visualized
by fluorescence quenching under UV light or by staining with iodine. Other reagents were
purchased from Sigma-Aldrich (St. Louis, MO), Alfa Aesar (Ward Hill, MA), EMD Millipore
(Billerica, MA), or Oakwood Chemical (West Columbia, SC) and used without further
purification. 1H NMR and 13C NMR spectra for characterization of new compounds and
monitoring reactions were collected in CDCl3 (Cambridge Isotope Laboratories, Cambridge,
MA) on a JEOL 500 MHz spectrometer or Bruker 400 MHz spectrometer in the Department of
Chemistry at Southern Methodist University. All chemical shifts are reported in the standard
notation of parts per million using the peak of residual proton signals of the deuterated solvent as
an internal reference. Coupling constant units are in Hertz (Hz). Splitting patterns are indicated
as follows: br, broad; s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; dd, doublet of
doublets; dt, doublet of triplets. High resolution mass spectroscopy was performed on a
Shimadzu IT-TOF (ESI source) at the Shimadzu Center for Advanced Analytical Chemistry at
the University of Texas, Arlington. Low resolution mass spectrometry was performed using an
Advion ExpressionL CMS (ESI source) at Southern Methodist University.
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Fluorescence responses were acquired with a Hitachi F-7000 Fluorescence Spectrophotometer
(Hitachi, Tokyo, Japan) using the fluorescence detection mode. Fluorescence emission scans
were acquired in wavelength scan mode with emission wavelength range from 400 nm to 700
nm, and scan speed set to 1200 nm/min. Response time was set to 2.0 s. Absorbance responses
were acquired with a DU 800 spectrometer (Beckman Coulter, USA) using the absorbance
wavelength scan mode with the absorbance wavelength range from 200 nm to 850 nm, and scan
speed set to 1200 nm/min. Compounds were purified by recrystallization before spectroscopic
experiments. All measurements were obtained in a clean, 1.0 cm pathlength quartz cuvette with
screw cap on (Starna Cells, USA). Dichloromethane and trifluoroacetic acid were purchased
from Fisher Scientific.
1.4.2 Synthesis procedure
O
N

N

O

N

1

3',6'-bis(diethylamino)-2-phenylspiro[isoindoline-1,9'-xanthen]-3-one (1).1
Rhodamine B (2.99 g, 6.24 mmol, 1.0 equiv) and aniline (1.7 mL, 19 mmol, 3.0 equiv) were
dissolved in dichloromethane (50 mL). The mixture was cooled to 0 °C, then POCl3 (0.70 mL,
7.5 mmol, 1.2 equiv) was added dropwise. The reaction mixture was allowed to stir at 0 °C for
15 min and then heated to 45 °C for 20 h. The mixture was diluted with 50 mL dichloromethane,
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and washed with 1 M HCl (3 x 50 mL), 1 M NaOH (3 x 50 mL), and brine. The organic layer
was collected, dried over Na2SO4, filtered, and concentrated under reduced pressure. The crude
product was purified by silica gel chromatography with ethyl acetate: hexane (1:4) as the eluent,
affording the product as a white solid (2.4 g, 75% yield). The compound can be additionally
purified by recrystallization from ethyl acetate: hexanes (1:2). 1H NMR (500 MHz, CDCl3) 7.87
(dd, J = 6.9 Hz, 1.2 Hz, 1H), 7.50–7.58 (m, 2H), 6.80–6.93 (m, 6H), 7.61 (d, J = 8.6 Hz, 2H),
6.40 (d, J = 8.6 Hz, 2H), 6.27 (d, J = 2.3 Hz, 2H), 3.34 (q, J = 6.9 Hz, 8H), 1.11 (t, J = 6.9 Hz,
12H). 13C NMR (125 MHz, CDCl3) 166.9, 153.9, 152.9, 148.8, 137.7, 132.9, 130.7, 128.7,
128.2, 126.6, 126.1, 123.3, 122.4, 108.2, 106.3, 97.7, 67.3, 44.3, 12.5.
OCH3

O
N

N

O

N

2

3',6'-bis(diethylamino)-2-phenyl-4-methoxyspiro[isoindoline-1,9'-xanthen]-3-one (2).i
Rhodamine B (2.95 g, 6.22 mmol, 1.0 equiv) and 4-methoxy aniline (2.2 mL, 18.6 mmol, 2.9
equiv) were dissolved in dichloromethane (50 mL). The mixture was cooled to 0 °C, then POCl3
(0.70 mL, 7.5 mmol, 1.2 equiv) was added dropwise. The reaction mixture was allowed to stir at
0 °C for 15 min and then heated to 45 °C for 20 h. The mixture was diluted with 50 mL
dichloromethane and then washed with 1 M HCl (3 x 50 mL), 1 M NaOH (3 x 50 mL) and brine.
The organic layer was collected, dried over Na2SO4, filtered, and concentrated under reduced
pressure. The crude product was purified by silica gel chromatography with ethyl acetate: hexane
(1:4) as the eluent, affording the product as a white solid (2.2 g, 71% yield). The compound can
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be additionally purified by recrystallization from ethyl acetate: hexanes (1:2). 1H NMR (500
MHz, CDCl3) 8.03 (d, J = 6.3 Hz, 1H), 7.52 (t, J = 6.4 Hz, 2H), 7.19 (d, J = 6.4 Hz, 1H), 6.65 (q,
J = 8.5 Hz, 6H), 6.34 (d, J = 8.8 Hz, 2H), 6.27 (s, 2H), 3.80 (s, 3H), 3.71 (s, 3H), 3.34 (q, 8H),
1.17 (t, J = 6.9 Hz, 12H). 13C NMR (125 MHz, CDCl3) 167.6, 158.2, 153.2, 153.0, 148.7, 132.6,
131.4, 129.0, 128.9, 128.1, 124.0, 123.3, 122.0, 113.9, 108.0, 106.3, 97.7, 67.3, 55.1, 44.3, 12.5.

N

O

OCH3

N

OCH3

O

N

3

3',6'-bis(diethylamino)-2-phenyl-3,4-dimethoxyspiro[isoindoline-1,9'-xanthen]-3-one (3).
Rhodamine B (2.97 g, 6.24 mmol, 1.0 equiv) and 3,4-dimethoxy aniline (2.74 g, 18.7 mmol, 3.0
equiv) were dissolved in dichloromethane (50 mL). The mixture was cooled to 0 °C, then POCl3
(0.70 mL, 7.5 mmol, 1.2 equiv) was added dropwise. The reaction mixture was allowed to stir at
0 °C for 15 min and then heated to 45 °C for 20 h. The mixture was diluted with 50 mL
dichloromethane and then washed with 1 M HCl (3 x 50 mL), 1 M NaOH (3 x 50 mL) and brine.
The organic layer was collected, dried over Na2SO4, filtered, and concentrated under reduced
pressure. The crude product was purified by silica gel chromatography with ethyl acetate: hexane
(1:4) as the eluent, affording the product as a white solid (2.07 g, 54% yield). The compound can
be additionally purified by recrystallization from ethyl acetate: hexanes (1:2). 1H NMR (500
MHz, CDCl3) 8.03 (d, J = 6.3 Hz, 1H), 7.52 (t, 2H), 7.19 (d, J = 6.4 Hz, 1H), 6.65 (q, 6H), 6.34
(d, J = 8.8 Hz, 2H), 6.27 (s, 1H), 3.71 (s, 3H), 3.34 (q, 8H), 1.17 (t, J = 6.9 Hz, 12H). 13C NMR
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(125 MHz, CDCl3) 167.6, 158.2, 153.2, 153.0, 148.7, 132.6, 131.4, 129.0, 128.9, 128.1, 124.0,
123.3, 122.0, 113.9, 108.0, 106.3, 97.7, 67.3, 55.1, 44.3, 12.5.

4

3',6'-bis(diethylamino)-2-phenyl-2-fluorospiro[isoindoline-1,9'-xanthen]-3-one (4).ii
Rhodamine B (1.02 g, 2.09 mmol, 1.0 equiv) and 2-fluoro aniline (0.60 mL, 6.30 mmol, 3.1
equiv) were dissolved in dichloromethane (20 mL). The mixture was cooled to 0 °C, then POCl3
(0.23 mL, 2.5 mmol, 1.2 equiv) was added dropwise. The reaction mixture was allowed to stir at
0 °C for 15 min and then heated to 45 °C for 20 h. The mixture was diluted with 20 mL
dichloromethane and then washed with 1 M HCl (3 x 20 mL), 1 M NaOH (3 x 20 mL) and brine.
The organic layer was collected, dried over Na2SO4, filtered, and concentrated under reduced
pressure. The crude product was purified by silica gel chromatography with ethyl acetate: hexane
(1:3) as the eluent, affording the product as a white solid (0.96 g, 85% yield). The compound can
be additionally purified by recrystallization from ethyl acetate: hexanes (1:2). 1H NMR (500
MHz, CDCl3) 8.02 (m, 1H), 7.50–7.46 (m,2H), 7.14–7.12 (m, 1H), 7.05 (s, 1H), 6.98-6.94 (m,
2H), 6.64–6.60 (d, J = 8.0 Hz, 4H), 6.32–6.30 (d, J = 7.6 Hz, 2H), 6.21 (s, 2H), 3.30–3.26 (q, J =
7.0 Hz, 8H), 2.18 (d, J = 1.2 Hz, 3H), 1.17–1.13 (t, J = 7.0 Hz, 12H); 13C NMR (125 MHz,
CDCl3) 167.6, 153.2, 153.1, 148.6, 136.3, 133.7, 132.6, 131.1, 129.2, 128.9, 128.0, 127.3, 123.9,
123.3, 108.0, 106.4, 97.7, 67.2, 44.3, 21.1, 12.5.
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5

3',6'-bis(diethylamino)-2-phenyl-4-chlorospiro[isoindoline-1,9'-xanthen]-3-one (5).2
Rhodamine B (1.01 g, 2.08 mmol, 1.0 equiv) and 3-chloro aniline (0.66 mL, 6.25 mmol, 3.0
equiv) were dissolved in dichloromethane (20 mL). The mixture was cooled to 0 °C, then POCl3
(0.23 mL, 2.5 mmol, 1.2 equiv) was added dropwise. The reaction mixture was allowed to stir at
0 °C for 15 min and then heated to 45 °C for 20 h. The mixture was diluted with 20 mL
dichloromethane and then washed with 1 M HCl (3 x 20 mL), 1 M NaOH (3 x 20 mL) and brine.
The organic layer was collected, dried over Na2SO4, filtered, and concentrated under reduced
pressure. The crude product was purified by silica gel chromatography with ethyl acetate: hexane
(1:3) as the eluent, affording the product as a white solid (0.73 g, 71% yield). The compound can
be additionally purified by recrystallization from ethyl acetate: hexanes (1:2). 1H NMR (500
MHz, CDCl3) 8.02–7.99 (m, 1H), 7.50–7.46 (m, 2H), 7.15–7.12 (m, 1H), 7.08–7.06 (d, J = 7.0
Hz, 1H), 7.04−7.02 (m, 2H), 6.66–6.64 (d, J = 8.2 Hz, 4H), 6.33–6.30 (d, J = 8.6 Hz, 2H), 6.26
(s, 2H), 3.34–3.29 (q, J= 7.0 Hz, 8H), 2.21 (d, J= 1.2 Hz, 3H), 1.17–1.13 (t, J = 7.0 Hz, 12H). 13C
NMR (125 MHz, CDCl3) 167.6, 153.2,153.1, 148.6, 136.3, 133.7, 132.6, 131.1, 129.2, 128.9,
128.0,127.3, 123.9, 123.3, 108.0, 106.4, 97.7, 67.2, 44.3, 21.1, 12.5.
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6

3',6'-bis(diethylamino)-2-phenyl-3-fluorospiro[isoindoline-1,9'-xanthen]-3-one (6).2
Rhodamine B (1.02 g, 2.09 mmol, 1.0 equiv) and 3-fluoro aniline (0.61 mL, 6.33 mmol, 3.1
equiv) were dissolved in dichloromethane (20 mL). The mixture was cooled to 0 °C, then POCl3
(0.23 mL, 2.5 mmol, 1.2 equiv) was added dropwise. The reaction mixture was allowed to stir at
0 °C for 15 min and then heated to 45 °C for 20 h. The mixture was diluted with 20 mL
dichloromethane and then washed with 1 M HCl (3 x 20 mL), 1 M NaOH (3 x 20 mL) and brine.
The organic layer was collected, dried over Na2SO4, filtered, and concentrated under reduced
pressure. The crude product was purified by silica gel chromatography with ethyl acetate: hexane
(1:3) as the eluent, affording the product as a white solid (0.77 g, 71% yield). The compound can
be additionally purified by recrystallization from ethyl acetate: hexanes (1:2). 1H NMR (500
MHz, CDCl3) 8.02 (m, 1H), 7.50–7.46 (m, 2H), 7.14–7.12 (m, 1H), 7.08–7.06 (d, J= 7.0 Hz,
1H), 7.02−7.0 (m, 2H), 6.63–6.61 (d, J = 7.6 Hz, 4H), 6.33–6.30 (d, J = 8.4 Hz, 2H), 6.23 (s,
2H), 3.30–3.26 (q, J = 7.0 Hz, 8H), 2.18 (d, J = 1.2 Hz, 3H), 1.17–1.13 (t, J = 7.0 Hz, 12H). 13C
NMR (125 MHz, CDCl3) 167.6, 153.2,153.1, 148.6, 136.3, 133.7, 132.6, 131.1, 129.2, 128.9,
128.0,127.3, 123.9, 123.3, 108.0, 106.4, 97.7, 67.2, 44.3, 21.1, 12.5.
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7

3',6'-bis(diethylamino)-2-phenyl-2-methylspiro[isoindoline-1,9'-xanthen]-3-one (7).ii
Rhodamine B (0.997 g, 2.07 mmol, 1.0 equiv) and 2-methyl aniline (0.61 mL, 5.54 mmol, 2.7
equiv) were dissolved in dichloromethane (20 mL). The mixture was cooled to 0 °C, then POCl3
(0.23 mL, 2.5 mmol, 1.2 equiv) was added dropwise. The reaction mixture was allowed to stir at
0 °C for 15 min and then heated to 45 °C for 20 h. The mixture was diluted with 20 mL
dichloromethane and then washed with 1 M HCl (3 x 20 mL), 1 M NaOH (3 x 20 mL) and brine.
The organic layer was collected, dried over Na2SO4, filtered, and concentrated under reduced
pressure. The crude product was purified by silica gel chromatography with ethyl acetate: hexane
(1:3) as the eluent, affording the product as a white solid (0.56 g, 43% yield). The compound can
be additionally purified by recrystallization from ethyl acetate:hexanes (1:2). 1H NMR (500
MHz, CDCl3) 8.02–7.99 (m, 1H), 7.50–7.46 (m, 2H), 7.16–7.15 (m, 1H), 6.93–6.91 (d, J = 7.0
Hz, 2H), 6.66–6.64 (d, J = 8.2 Hz, 4H), 6.33–6.30 (d, J = 8.6 Hz, 2H), 6.26 (s, 2H), 3.34–3.29 (q,
J = 7.0 Hz, 8H), 2.21 (d, J = 1.2 Hz, 3H), 1.17–1.13 (t, J = 7.0 Hz, 12H). 13C NMR (125 MHz,
CDCl3) 167.6, 153.2,153.1, 148.6, 136.3, 133.7, 132.6, 131.1, 129.2, 128.9, 128.0,127.3, 123.9,
123.3, 108.0, 106.4, 97.7, 67.2, 44.3, 21.1, 12.5.
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8

3',6'-bis(diethylamino)-2-phenyl-2,6-dimethylspiro[isoindoline-1,9'-xanthen]-3-one (8).ii
Rhodamine B (1.05 g, 2.10 mmol, 1.0 equiv) and 2,6-dimethyl aniline (0.78 mL, 6.32 mmol, 3.0
equiv) were dissolved in dichloromethane (20 mL). The mixture was cooled to 0 °C, then POCl3
(0.23 mL, 2.5 mmol, 1.2 equiv) was added dropwise. The reaction mixture was allowed to stir at
0 °C for 15 min and then heated to 45 °C for 20 h. The mixture was diluted with 20 mL
dichloromethane and then washed with 1 M HCl (3 x 20 mL), 1 M NaOH (3 x 20 mL) and brine.
The organic layer was collected, dried over Na2SO4, filtered, and concentrated under reduced
pressure. The crude product was purified by silica gel chromatography with ethyl acetate: hexane
(1:3) as the eluent, affording the product as a white solid (0.85 g, 62% yield). The compound can
be additionally purified by recrystallization from ethyl acetate: hexanes (1:2). 1H NMR (500
MHz, CDCl3) 8.08 (d, J = 7.4 Hz, 1H), 7.70−7.62 (m, 2H), 7.42 (d, J = 7.4 Hz, 1H), 7.03 (t, J =
7.4 Hz, 1H), 6.83 (d, J = 7.4 Hz, 2H), 6.56 (d, J = 9.0 Hz, 2H), 6.28 (dd, J = 8.8 Hz, 2.6 Hz, 2H),
6.23 (d, J = 2.4 Hz, 2H), 3.31 (q, J = 7.0, 8H), 1.35 (s, 6H), 1.12 (t, J = 7.1, 12H). 13C NMR (125
MHz, CDCl3) 166.0, 155.9, 149.0, 148.6, 139.0, 133.6, 132.4, 132.1, 129.4, 128.7, 127.9, 127.7,
124.8, 123.9, 109.0, 107.4, 98.4, 69.4, 44.5, 18.3, 12.4.
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9

3',6'-bis(diethylamino)-2-phenyl-2,6-diisopropylspiro[isoindoline-1,9'-xanthen]-3-one (9).ii
Rhodamine B (1.01 g, 2.08 mmol, 1.0 equiv) and 2,6-diisopropyl aniline (1.11g, 6.26 mmol, 3.0
equiv) were dissolved in dichloromethane (20 mL). The mixture was cooled to 0 °C, then POCl3
(0.23 mL, 2.5 mmol, 1.2 equiv) was added dropwise. The reaction mixture was allowed to stir at
0 °C for 15 min and then heated to 45 °C for 20 h. The mixture was diluted with 20 mL
dichloromethane and then washed with 1 M HCl (3 x 20 mL), 1 M NaOH (3 x 20 mL) and brine.
The organic layer was collected, dried over Na2SO4, filtered, and concentrated under reduced
pressure. The crude product was purified by silica gel chromatography with ethyl acetate: hexane
(1:3) as the eluent, affording the product as a white solid (0.66 g, 53% yield). The compound can
be additionally purified by recrystallization from ethyl acetate: hexanes (1:2). 1H NMR (500
MHz, CDCl3) 8.08 (d, J = 7.4 Hz, 1H), 7.68-7.66 (m, 2H), 7.42 (d, J = 7.0 Hz, 1H), 7.02 (t, J =
7.0 Hz, 1H), 6.80 (d, J = 7.2 Hz, 2H), 6.56 (d, J = 9.0 Hz, 2H), 6.28 (d d, J= 9.0 Hz, 2.6 Hz, 2H),
6.23 (d, J = 2.8 Hz, 2H), 3.31 (q, J= 7.0, 8H), 1.72 (s, 12H), 1.12 (t, J= 7.1, 12H). 13C NMR (125
MHz, CDCl3) 166.0, 155.9, 149.0, 148.6, 139.0, 133.6, 132.4, 132.1, 129.4, 128.7, 127.9, 127.7,
124.8, 123.9, 109.0, 107.4, 98.4, 69.4, 44.5, 18.3, 12.4.
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bis-triflate

3-oxo-3H-spiro[isobenzofuran-1,9'-xanthene]-3',6'-diyl bis(trifluoromethanesulfonate).
Fluorescein (2.79 g, 8.42 mmol, 1.0 equiv) and bis(trifluoromethanesulfonyl) aniline (7.52 g,
21.1 mmol, 2.5 equiv) were dissolved in dichloromethane (20 mL). Then diisopropylethylamine
(4.31 mL, 25.2 mmol, 3.0 equiv) was added into the mixture. The reaction mixture was allowed
to stir at 25 °C for 18h. The reaction was monitored by TLC. Upon completion, the mixture was
diluted with 20 mL dichloromethane and then washed with 1 M HCl (3 x 20 mL), 1 M NaHCO3
(3 x 20 mL) and brine. The organic layer was collected, dried over Na2SO4, filtered, and
concentrated under reduced pressure. The crude product was purified by silica gel
chromatography with dichloromethane:methanol (20:1) as the eluent, affording the product as a
light yellow solid (3.56 g, 71% yield). 1H NMR (500 MHz, CDCl3) 8.05 (d, J = 7.0 Hz, 1H),
7.73-7.69 (m, 2H), 7.29 (s, 2H), 7.19 (d, J = 6.6 Hz, 1H), 7.01-6.97 (m, 4H). 13C NMR (125
MHz, CDCl3) 168.7, 152.1, 151.4, 150.2, 131.0, 130.0, 125.8, 123.7, 119.3, 117.7, 110.7, 80.1.

rhodamine-CF3
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3',6'-bis((2,2,2-trifluoroethyl)amino)-3H-spiro[isobenzofuran-1,9'-xanthen]-3-one. The pure
bis-triflate product (2.98 g, 5.04 mmol, 1 equiv) was added into a 50 mL pressure flask with
Pd2(dba)3 (462 mg, 0.504 mmol, 0.1 equiv), XPhos (720 mg, 1.51 mmol, 0.3 equiv) and Cs2CO3
(4.60 g, 14.1 mmol, 2.8 equiv). The flask was vacuumed and filled with N2 for 10 min. Then, the
mixture was dissolved in 20 mL dioxane and stirred for 15 min under N2. 2,2,2trifluoroethylamine (0.92 mL, 12.9 mmol, 2.4 equiv) was added into the mixture by dropwise
addition. The flask was capped and heated at 100 °C for 20 h. The mixture was then transferred
into round bottle and evaporated all the solvent. The residue was poured into brine (50 mL), 1 M
HCl (10 mL) was added, and the mixture was extracted with ethyl acetate (3 × 25 mL). The
organic layer was collected, dried over Na2SO4, filtered, and concentrated under reduced
pressure. The crude product was purified by silica gel chromatography with dichloromethane:
methanol (30:1) as the eluent, affording the product as a red solid (1.59 g, 64% yield). 1H NMR
(500 MHz, CDCl3) 7.99 (m, 1H), 7.65 (m, 1H), 7.59 (m, 1H), 7.17 (d, 1H), 6.58 (s, 2H), 6.51 (m,
2H), 6.36 (t, J = 8.3 Hz, 2H), 4.23 (s, 2H), 3.78 (m, 4H). 13C NMR (125 MHz, CDCl3) 167.7,
154.8, 154.0, 133.3, 131.9, 130.6, 128.7, 123.9, 108.7, 98.1, 69.3, 44.6, 37.9, 30.0, 14.9, 12.6.
HRMS calculated for C24H16N2O3F6 [M+H]+ 495.1121, found 495.1119.

10

2-phenyl-3',6'-bis((2,2,2-trifluoroethyl)amino)spiro[isoindoline-1,9'-xanthen]-3-one (10).
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Rhodamine-CF3 (305 mg, 0.607 mmol, 1.0 equiv) and aniline (0.17 mL, 1.82 mmol, 3.0 equiv)
were dissolved in dichloromethane (10 mL). The mixture was cooled to 0 °C, then POCl3 (0.07
mL, 0.73 mmol, 1.2 equiv) was added dropwise. The reaction mixture was allowed to stir at 0 °C
for 15 min and then heated to 45 °C for 20 h. The mixture was diluted with 10 mL
dichloromethane and then washed with 1 M HCl (3 x 10 mL), 1 M NaOH (3 x 10 mL) and brine.
The organic layer was collected, dried over Na2SO4, filtered, and concentrated under reduced
pressure. The crude product was purified by silica gel chromatography with ethyl acetate:hexane
(1:4) as the eluent, affording the product as a white solid (141.2 mg, 40% yield). The compound
can be additionally purified by recrystallization from ethyl acetate: hexanes (1:2). 1H NMR
(500 MHz, CDCl3) 8.01 (d, J = 7.1 Hz, 1H), 7.54–7.50 (m, 2H), 7.14−7.08 (m, 4H), 6.54 (d, J
= 8.0 Hz, 4H), 6.30 (d, J = 8.6 Hz, 4H), 3.73 (q, J = 6.6 Hz, 4H). 13C NMR (125 MHz, CDCl3)
167.6, 152.7, 147.0, 135.9, 132.9, 131.3, 129.1, 127.3, 126.2, 123.7, 110.3, 99.3, 67.1, 45.9, 29.7.
HRMS calculated for C30H21N3O2F6 [M+H]+ 570.1533, found 570.1531.

11

2-(2-fluorophenyl)-3',6'-bis((2,2,2-trifluoroethyl)amino)spiro[isoindoline-1,9'-xanthen]-3one (11). Rhodamine-CF3 (311 mg, 0.607 mmol, 1.0 equiv) and 2-fluoro aniline (0.18 mL, 1.83
mmol, 2.9 equiv) were dissolved in dichloromethane (10 mL). The mixture was cooled to 0 °C,
then POCl3 (0.07 mL, 0.73 mmol, 1.2 equiv) was added dropwise. The reaction mixture was
allowed to stir at 0 °C for 15 min and then heated to 45 °C for 20 h. The mixture was diluted
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with 10 mL dichloromethane and then washed with 1 M HCl (3 x 10 mL), 1 M NaOH (3 x 10
mL) and brine. The organic layer was collected, dried over Na2SO4, filtered, and concentrated
under reduced pressure. The crude product was purified by silica gel chromatography with ethyl
acetate:hexane (1:2) as the eluent, affording the product as a white solid (221.4 mg, 62% yield).
The compound can be additionally purified by recrystallization from ethyl acetate: hexanes (1:2).
1

H NMR (500 MHz, CDCl3) 8.01−8.05 (m, 1H), 7.54 (t, J = 4.9 Hz, 2H), 7.12−7.16 (m, 2H),

6.77 (t, J = 10.3 Hz, 1H), 6.61 (d, J = 8.6 Hz, 2H), 6.57 (m, 2H), 6.31 (dd, J = 2.3, 8.6 Hz, 4H),
4.12 (t, J = 8.8 Hz, 2H), 3.73 (p, J = 13.3 Hz, 4H). 13C NMR (125 MHz, CDCl3) 166.8, 159.6,
152.9, 152.6, 147.6, 133.1, 130.9, 129.8, 129.5, 129.0, 128.7, 125.9, 124.0, 123.9, 123.7, 116.4,
116.2, 110.2, 109.6, 99.0, 66.9, 53.4, 45.9, 45.6, 29.7. HRMS calculated for C30H20N3O2F7
[M+H]+ 588.15, found 588.15.

12

2-(2,6-diisopropylphenyl)-3',6'-bis((2,2,2-trifluoroethyl)amino)spiro[isoindoline-1,9'xanthen]-3-one (12). Rhodamine-CF3 (152 mg, 0.307 mmol, 1.0 equiv) and 2,6-diisopropyl
aniline (0.16 g, 0.906 mmol, 2.9 equiv) were dissolved in dichloromethane (10 mL). The mixture
was cooled to 0 °C, then POCl3 (0.04 mL, 0.36 mmol, 1.2 equiv) was added dropwise. The
reaction mixture was allowed to stir at 0 °C for 15 min and then heated to 45 °C for 20 h. The
mixture was diluted with 10 mL dichloromethane and then washed with 1 M HCl (3 x 10 mL), 1
M NaOH (3 x 10 mL) and brine. The organic layer was collected, dried over Na2SO4, filtered,
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and concentrated under reduced pressure. The crude product was purified by silica gel
chromatography with ethyl acetate: hexane (1:3) as the eluent, affording the product as a white
solid (120.1mg, 62% yield). The compound can be additionally purified by recrystallization from
ethyl acetate:hexanes (1:2). 1H NMR (500 MHz, CDCl3) 8.06 (d, J = 6.9 Hz, 1H), 7.63 (m, 1H),
7.03 (d, J = 7.6 Hz, 2H), 6.97 (m, 2H), 6.82 (m, 2H), 6.59–6.57 (m, 1H), 6.33 (d, J = 6.8 Hz, 2H),
6.26 (d, J = 5.4 Hz, 2H), 3.72 (m, 4H), 2.30 (m, 2H), 1.16 (s, 2H), 0.88 (d, J = 6.9 Hz, 6H), 0.41
(d, J = 6.3 Hz, 6H). 13C NMR (125 MHz, CDCl3) 167.6, 157.0, 150.3, 133.8, 130.3, 129.7, 127.4,
123.6, 123.2, 112.0, 110.3, 100.2, 70.0, 45.4, 28.6, 21.4. HRMS calculated for C36H33N3O2F6
[M+H]+ 654.2550, found 654.2548.

13

2-(o-tolyl)-3',6'-bis((2,2,2-trifluoroethyl)amino)spiro[isoindoline-1,9'-xanthen]-3-one (13).
Rhodamine-CF3 (201.5 mg, 0.40 mmol, 1.0 equiv) and o-toluidine (0.13 mL, 1.21 mmol, 3.0
equiv) were dissolved in dichloromethane (10 mL). The mixture was cooled to 0 °C, then POCl3
(0.04 mL, 0.48 mmol, 1.2 equiv) was added dropwise. The reaction mixture was allowed to stir
at 0 °C for 15 min and then heated to 45 °C for 20 h. The mixture was diluted with 10 mL
dichloromethane and then washed with 1 M HCl (3 x 10 mL), 1 M NaOH (3 x 10 mL) and then
washed with brine. The organic layer was collected, dried over Na2SO4, filtered, and
concentrated under reduced pressure. The crude product was purified by silica gel
chromatography with ethyl acetate:hexane (1:4) as the eluent, affording the product as a white
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solid (134 mg, 37% yield). The compound can be additionally purified by recrystallization from
ethyl acetate: hexanes (1:2). 1H NMR (500 MHz, CDCl3) 8.01 (d, J = 7.1 Hz, 1H), 7.54–7.50 (m,
2H), 7.14−7.08 (m, 4H), 6.62 (q, J = 8.5 Hz, 6H), 6.30 (d, J = 8.0 Hz, 2H), 6.27 (s, 2H), 3.73 (q,
J = 6.6 Hz, 4H). 13C NMR (125 MHz, CDCl3) 165.9, 154.2, 153.7, 152.9, 150.9, 147.8, 138.1,
133.7, 132.5, 130.6, 130.1, 129.1, 128.2, 125.7, 123.6, 116.4, 111.5, 110.6, 109.1, 99.5, 67.4,
45.6, 18.2. HRMS calculated for C31H23N3O2F6 [M+H]+ 584.1783, found 584.1767.

14

2-(3,4-dimethoxyphenyl)-3',6'-bis((2,2,2-trifluoroethyl)amino)spiro[isoindoline-1,9'xanthen]-3-one (14). Rhodamine-CF3 (201.7 mg, 0.40 mmol, 1.0 equiv) and 3,4-dimethoxy
aniline (184 mg, 1.21 mmol, 3.0 equiv) were dissolved in dichloromethane (10 mL). The mixture
was cooled to 0 °C, then POCl3 (0.04 mL, 0.48 mmol, 1.2 equiv) was added dropwise. The
reaction mixture was allowed to stir at 0 °C for 15 min and then heated to 45 °C for 20 h. The
mixture was diluted with 20 mL dichloromethane and then washed with 1 M HCl (3 x 10 mL), 1
M NaOH (3 x 10 mL) and brine. The organic layer was collected, dried over Na2SO4, filtered,
and concentrated under reduced pressure. The crude product was purified by silica gel
chromatography with ethyl acetate:hexane (1:3) as the eluent, affording the product as a white
solid (382 mg, 75% yield). The compound can be additionally purified by recrystallization from
ethyl acetate: hexanes (1:2). 1H NMR (500 MHz, CDCl3) 8.02 (d, J = 7.1 Hz, 1H), 7.57–7.55 (m,
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2H), 7.17−7.15 (m, 1H), 6.65 (q, J = 7.8 Hz, 2H), 6.59 (d, J = 6.6 Hz, 1H), 6.34 (d, J = 8.0 Hz,
2H), 6.29 (s, 2H), 6.21 (m, 1H), 6.04 (s, 1H), 3.79 (q, J = 6.6 Hz, 4H), 3.45 (s, 6H). 13C NMR
(125 MHz, CDCl3) 167.3, 153.7, 151.7, 147.9, 147.5, 132.9, 131.4, 129.3, 128.2, 124.1, 123.5,
120.7, 110.9, 109.9, 99.2, 67.0, 55.8, 45.6. HRMS calculated for C32H25N3O4F6 [M+H]+
630.1824, found 630.1822.

15

2-(4-methoxyphenyl)-3',6'-bis((2,2,2-trifluoroethyl)amino)spiro[isoindoline-1,9'-xanthen]-3one (15). Rhodamine-CF3 (203 mg, 0.41 mmol, 1.0 equiv) and 4-methoxy aniline (0.10 mL,
1.23 mmol, 3.0 equiv) were dissolved in dichloromethane (10 mL). The mixture was cooled to 0
°C, then POCl3 (0.04 mL, 0.50 mmol, 1.2 equiv) was added dropwise. The reaction mixture was
allowed to stir at 0 °C for 15 min and then heated to 45 °C for 20 h. The mixture was diluted
with 10 mL dichloromethane and then washed with 1 M HCl (3 x 10 mL), 1 M NaOH (3 x 10
mL) and brine. The organic layer was collected, dried over Na2SO4, filtered, and concentrated
under reduced pressure. The crude product was purified by silica gel chromatography with ethyl
acetate:hexane (1:3) as the eluent, affording the product as a white solid (158 mg, 45% yield).
The compound can be additionally purified by recrystallization from ethyl acetate: hexanes (1:2).
1

H NMR (500 MHz, CDCl3) 8.01 (d, J = 7.1 Hz, 1H), 7.54–7.50 (m, 2H), 7.14−7.08 (m, 4H),

6.62 (q, J = 8.5 Hz, 6H), 6.30 (d, J = 8.0 Hz, 2H), 6.27 (s, 2H), 3.73 (q, J = 6.6 Hz, 4H), 3.68 (s,
3H). 13C NMR (125 MHz, CDCl3) 166.9, 159.2, 153.9, 152.9, 147.8, 133.1, 131.0, 129.3, 128.2,
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126.6, 124.1, 123.7, 116.4, 115.6, 114.1, 110.2, 98.7, 67.3, 55.4, 45.6. HRMS calculated for
C31H23N3O3F6 [M+H]+ 600.1725, found 600.1716.

16

2-(2,6-dimethylphenyl)-3',6'-bis((2,2,2-trifluoroethyl)amino)spiro[isoindoline-1,9'-xanthen]3-one (16). Rhodamine-CF3 (302.4 mg, 0.61 mmol, 1.0 equiv) and 2,6-dimethyl aniline (0.22
mL, 1.82 mmol, 3.0 equiv) were dissolved in dichloromethane (10 mL). The mixture was cooled
to 0 °C, then POCl3 (0.07 mL, 0.73 mmol, 1.2 equiv) was added dropwise. The reaction mixture
was allowed to stir at 0 °C for 15 min and then heated to 45 °C for 20 h. The mixture was diluted
with 10 mL dichloromethane and then washed with 1 M HCl (3 x 10 mL), 1 M NaOH (3 x 10
mL) and brine. The organic layer was collected, dried over Na2SO4, filtered, and concentrated
under reduced pressure. The crude product was purified by silica gel chromatography with ethyl
acetate: hexane (1:4) as the eluent, affording the product as a white solid (241 mg, 67% yield).
The compound can be additionally purified by recrystallization from ethyl acetate: hexanes (1:2).
1

H NMR (500 MHz, CDCl3) 8.06 (d, J = 7.4 Hz, 1H), 7.66–7.62 (m, 2H), 7.37 (m, 1H),

7.02−6.96 (m, 2H), 6.82 (q, J = 8.4 Hz, 2H), 6.57 (d, J = 6.6 Hz, 2H), 6.28 (d, J = 8.0 Hz, 4H),
4.08 (q, J = 6.8 Hz, 2H), 3.73 (q, J = 6.6 Hz, 4H), 2.09 (s, 6H). 13C NMR (125 MHz, CDCl3)
167.1, 152.2, 147.8, 138.1, 133.7, 132.5, 130.6, 130.1, 129.1, 128.2, 125.7, 123.6, 116.4, 111.5,
110.6, 109.1, 99.5, 67.4, 45.6, 18.2. HRMS calculated for C32H25N3O3F6 [M+H]+ 598.1944,
found 598.1935.
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17

2-(3-chlorophenyl)-3',6'-bis((2,2,2-trifluoroethyl)amino)spiro[isoindoline-1,9'-xanthen]-3one (17). Rhodamine-CF3 (172 mg, 0.347 mmol, 1.0 equiv) and 3-chloro aniline (0.10 mL, 0.86
mmol, 2.5 equiv) were dissolved in dichloromethane (10 mL). The mixture was cooled to 0 °C,
then POCl3 (0.04 mL, 0.34 mmol, 1.2 equiv) was added dropwise. The reaction mixture was
allowed to stir at 0 °C for 15 min and then heated to 45 °C for 20 h. The mixture was diluted
with 10 mL dichloromethane and then washed with 1 M HCl (3 x 10 mL), 1 M NaOH (3 x 10
mL) and brine. The organic layer was collected, dried over Na2SO4, filtered, and concentrated
under reduced pressure. The crude product was purified by silica gel chromatography with ethyl
acetate: hexane (1:2) as the eluent, affording the product as a white solid (117 mg, 68% yield).
The compound can be additionally purified by recrystallization from ethyl acetate: hexanes (1:2).
1

H NMR (500 MHz, CDCl3) 8.00 (d, J = 6.8 Hz, 1H), 7.54–7.50 (m, 2H), 7.11−7.02 (m, 3H),

6.81 (s, 1H), 6.60 (q, J = 8.3 Hz, 3H), 6.33 (d, J = 8.2 Hz, 4H), 4.1 (m, 2H), 3.75 (q, J = 6.6 Hz,
4H). 13C NMR (125 MHz, CDCl3) 167.3, 147.6, 137.6, 134.1, 133.2, 130.6, 130.1, 129.7, 128.9,
126.7, 125.8, 124.8, 110.6, 109.7, 99.0, 67.2, 45.9. HRMS calculated for C30H20N3O2F6Cl
[M+H]+ 604.1221, found 604.1221.
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1.4.3 Extinction coefficient measurements of on-state and off-state
1.4.3.1 Off-state measurements (254nm(off))
A 0.5 mM stock solution of recrystallized photoswitch was prepared in dichloromethane and
diluted to 1.0 mL solutions of five different concentrations between from 2 µM and 20 µM of
each photoswitch. 300 µL of each solution was transferred into a cuvette and absorbance scans
were acquired for each concentration. The concentrations were selected to ensure that
absorbances at 254 nm ranged between 0.10 and 1.00 absorbance units. Plots of photoswitch
concentration versus absorbance at 254 nm were generated and extinction coefficients were
calculated as the slope of the linear plot based on the Beer-Lambert law:
 = A / (c x l)
where  is the extinction coefficient, A is the absorbance of samples at 254 nm, c is the
concentration of the photoswitch, and l is the pathlength of the cuvette. All values are the
average of n = 3 independent experiments  standard deviation.
1.4.3.2 On-state measurements (495nm(on), 556nm(on))
0.5 mM stock solutions of every SRB derivative and 25 mM stock solution of trifluoroacetic
acid was prepared in dichloromethane, which were diluted with final concentrations between 1
µM and 30 µM of the photoswitches containing 50 equivalents of trifluoroacetic acid. The
solutions were capped and put into dark condition for 40 minutes to drive the photoswitches to
the fully fluorescent on-form. After incubation, 300 µL of the sample was transferred to a cuvette
and UV/Vis absorption spectra were obtained for each compound. The extinction coefficient was
determined according to the slope of the calibration curve of concentration/absorbance at 556 nm
for the SRB derivatives based on Lamber-Beer's law. For the SRCF3 probes, A similar protocol
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was used except using a 250 mM stock solution of trifluoroacetic acid for using with the SRCF3
derivatives.
1.4.4 Fluorescence quantum yield (fl) measurements
Based on the TFA adding experiments, fluorescence quantum yields of SRB derivatives were
determined with the addition of 50 equivalents of trifluoroacetic acid and SRCF3 derivatives
were determined with the addition of 500 equivalents of trifluoroacetic acid, both of them were
using rhodamine B as a standard. Five concentration spots of the standard rhodamine B were
prepared in ethanol that make sure all of the solution performed absorbance values between 0.01
and 0.1. A same method was used to prepare the SRB and SRCF3 derivatives solutions with
measuring the absorbance and exciting at 556 nm for the SRB derivatives and the absorbance
and exciting at 495 nm for the SRCF3 derivatives.
The fluorescence quantum yield was determined by using equation 1, where G is the slope of
the calibration curve of fluorescence emission intensity/absorbance, Gstand is the slope of the
same plot for the rhodamine b,  is the index of refraction for the sample solutions
(dichloromethane=1.42), stand is the index of refraction of the standard solution (ethanol= 1.36).
fl is the fluorescence quantum yield of the sample and stand is the fluorescence quantum yield
of the standard.

(1)
1.4.5 Determination of koff, kon, and Keq
Besides that, SRB and SRCF3 samples were prepared at 5 µM in dichloromethane in a quartz
cuvette and placed in a Hitachi F-7000 fluorescence spectrophotometer for measuring the
kinetics. For the SRB derivatives, the following parameters were used: ex = 254 nm, em = 585
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nm, excitation slits = 5 nm, emission slits = 2.5 nm and for the SRCF3 derivatives, the following
parameters were used: ex = 254 nm, em = 518 nm, excitation slits = 5 nm, emission slits = 5
nm. Time scans were performed with continuous excitation at 254 nm until an equilibrium was
reached (around 30 min). After that, the curves were fit to equation 2 for the first-order reaction
at equilibrium, where Ifl is the fluorescence emission intensity, Imax is the theoretical maximum
emission on complete turn-on state of sample, kon is the rate constant for the photoactivation
process, koff is the rate constant for the photoactivation process, B is a parameter to account for
background signal. Fitting result was performed using Mathematica 12.0 and values for Imax were
estimated by measuring the fluorescence emission with addition of excess trifluoroacetic acid,
which were used to confirm the value of Imax. This constraint could provide consistent values of
kon and koff. All values are the average of n = 3 independent experiments  standard deviation.
Keq was equaled to kon / koff.

(2)
1.4.6 Determination of the Photochemical Quantum Yield for Photoswitching to the OnState, pc
The photochemical quantum yields were determined using equation 3, where kon is the rate of
photochemical reaction determined by equation 2, 254nm is the extinction coefficient of the offstate at 254 nm, V is the total volume of the testing sample, I0 is the intensity of the excitation
light at 254 nm (50.8 µW cm–2, measured with a Digital Light Meter, ThorLabs PM100D) , and l
is the path length of the cuvette (1 cm). All values are the average of n = 3 independent
experiments  standard deviation.

41

(3)

1.5 Conclusions
In summary, we have successfully synthesized two series of fluorescent spirolactam rhodamine
photoswitches SRB and SRCF3 photoswitches with fluorescence emission in the red (585 nm) or
green (518 nm) of the spectrum. Then we obtained their important measurements such as
extinction coefficients, fluorescence and photochemical quantum yields, and kinetics of
photoactivation. In addition, we reported a novel synthetic method to synthesize SRCF3
photoswitches and using two different methods to evaluate kon and consequently quantum yields
pc, one of which was depended on the constraints for the Imax parameter. the other one related
with the maximum emission intensity of the photoswitch on its fully open form. At the same
time, we performed experiments using excess trifluoroacetic acid to drive the photoreaction
equilibriums to the fully on-state. Finally, volumetric 3D imaging is demonstrated in
dichloromethane with triethylamine addition by using DLP technology, that provides a valuable
example for exploring other applications like 3D printing.
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CHAPTER 2
CHEMILUMINESCENT PROBES FOR CELLULAR HYDROGEN SULFIDE DETECTION

2.1 Introduction
Reactive sulfur and nitrogen species like hydrogen sulfide and nitric oxide are cellular
signaling molecules which play important roles in physiology and medical science.1,2,3 Upon
their chemical reactions like oxidation and reduction, the detection and measurements of sulfur
and nitrogen species have been developed. Different with fluorescent probes, chemiluminescent
probes can detect specific species by chemiluminescent reactions that generate the light from
unique mechanisms without any light irradiation.4 In recent years, chemiluminescence probes are
widely used in detecting and measuring some biological reactive species like hydrogen sulfide in
in vitro and in vivo conditions.6,7 In this dissertation, we mainly discuss the 1,2-dioxetane
chemiluminescent probes for detecting, measuring, and imaging reactive species in vivo and in
vitro. We do the synthesis and measurements of CHS-4 and CL-DNP probes for hydrogen
sulfide. After doing the selectivity and kinetics tests of them in vitro, in vivo studies for
monitoring and imaging reactive sulfur and oxygen species in A549 cells are explored to
demonstrate that chemiluminescence holds great potential for in vivo imaging.
2.1.1 Chemiluminescence
Chemiluminescence is observed easily in our daily life in various formats, such as glow sticks,
bioluminescent bays, fireflies and so on.8,9 Chemiluminescence was first defined by Eilhard
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Wiedemann in 1888, which could be described as light emission from a chemical reaction.10
With more understanding of chemiluminescence, the mechanisms of chemiluminescence light
generation has been understood more clearly which provides us more useful applications in
biochemistry and medical areas.
Chemiluminescence is the light generated from a thermal reaction that is observed when the
product in an excited state relaxes to its ground state with emission of photons. It is normally
defined as a reaction that produces the energy to achieve the transition of an electron from its
ground state to an excited electronic state in chemiluminescent reaction.11 In chemistry and
biology research, chemiluminescence applications have various potential advantages such as
high sensitivity, wide linear range, simple and inexpensive instrumentation compared with
traditional fluorescence methods.12 The most important advantage of chemiluminescence is that
low background noise is produced from the elimination of an external light source, which could
improve sensitivity in large extent and provide more opportunities for in vivo imaging.

Figure 2-11 Potential energy diagrams. (A) an exothermic reaction (B) a chemiluminescent
reaction. (S = starting material, I = reactive intermediate or transition state, P = product).
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2.1.2 Reactive sulfur and nitrogen species
Reactive sulfur and nitrogen species like hydrogen sulfide and nitric oxide as representative
signaling molecules in medical area13 participate in various important activities in vivo. How to
complete accurate measurement of these species becomes a meaningful work, which need us to
obtain a deep understanding of their chemical and biological characterizations.
Hydrogen sulfide (H2S) as a representative chemical of reactive species, has been regarded as a
toxic gas to physiology systems for a long time, that could cause various diseases such as cancer,
Down’s syndrome and diabetes.14,15,16 However, accumulating evidence performs that except
being a harmful chemical and environmental pollutant, H2S also plays and important role in
mammalian systems,17 including some important biological functions like protecting against
cardiovascular disease and promoting vasorelaxation in animal’s body.18,19 As more studies
about hydrogen sulfide generation, there are two main pathways of H2S production in
physiological conditions. One is descried as non-enzymatic processes, which can be directly
generated from some sulfur containing species such as glucose, glutathione, inorganic and
organic polysulfides,20 the other is enzymatic processes with cystathionine gamma lyase (CSE)
21

, cystathionine beta synthase (CBS)22 and 3-mercaptopyruvate sulfurtransferase (3-MST)23 that

have been reported in some human organs. Therefore, H2S has been found that it has large
influence in most tissues of living systems, such as vasculature, brain, lungs, liver, and pancreas
in living systems.59,60,61,62
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Scheme 2-4 Enzymatic pathways for H2S generation.

As a signaling nitrogen reactive molecule, nitric oxide was firstly discovered that it could
achieve the activation of cyclase and help muscle cells complete relaxation in 1998.24 Similar
with hydrogen sulfide, some results are reported that nitric oxide could be produced in
physiological conditions which is generated from three isoforms of the nitric oxide synthase
(NOS) enzyme - neuronal NOS (nNOS, NOS-1), inducible NOS (iNOS, NOS-2), and endothelial
NOS (eNOS, NOS-3), all of them use L-arginine as precursor.25,26 The bacterial nitrate reduction
in the microbiome is discovered, which could also produce nitric oxide by nitrite reduction.27
According to these studies, nitric oxide plays an important and central roles in the cardiovascular
system as a small, diffusible, and reactive molecule.28,29,30 Additionally, nitric oxide can also
participate in cellular signaling, that use small molecules as reactive nitrogen species donors,
including peroxynitrite31 and decomposition products32, nitroxyl33, and nitrite/nitrate34.
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Scheme 2-5 The nitric oxide synthase (NOS) reactions with L-Arginine.

2.1.3 Chemiluminescent 1,2-dioxetane probes for reactive sulfur and nitrogen species
Except the traditional detecting methods for reactive sulfur and nitrogen species like HPLC
and methylene blue assay, reaction-based fluorescent probes have received enormous attention
over past decade, which is available to detect target molecule in live cells with higher emission
intensity and greater selectivity.35 These reaction-based methods take advantage of the chemical
reactivity of H2S, including nucleophilicity36, metal precipitation37 and reductivity38. (Scheme 26) However, there are some drawbacks of fluorescence imaging during in vivo measurements,
such as light scattering, phototoxicity, which affect the probe kinetics and sensitivity39.
Compared with it, a reaction-based chemiluminescent methods for reactive species could provide
a valuable choice to solve these problems. Several chemiluminescent systems have been reported
for reactive sulfur and nitrogen species in physiology, including luciferin/luciferase40, luminol41,
acridinium esters42, peroxyoxalates43, and 1,2-dioxetanes44,45. In this dissertation, we mainly
discuss the 1,2-dioxetane triggered chemiluminescent probes for reactive sulfur and nitrogen
molecules. Compared with other chemiluminescent probes, spiroadamantane 1,2-dioxetanes
could achieve the CIEEL mechanisms more stably as it is easily forming the “solvent cage”
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structure as protecting group and steric hinderance group of this structure could reduce the
proton activity of phenyl which improves the selectivity and sensitivity of chemiluminescence
generation. In recent years, with more studies about 1,2-dioxetane mechanisms, this class of
chemiluminescent probes was realized that it could be used for cell studies and in vivo imaging.
Furthermore, several new chemiluminescent probes have now been developed, including
chemiluminescent 1,2-dioxtane probes for reactive sulfur and nitrogen species.
In earlier years, some groups reported a novel dioxetane probe with dinitrophenyl group of
detecting H2S, that could produce the dioxetane phenol with nucleophilic aromatic substitution
reaction finally46. In addition, Baader reported that electron donating groups with the dioxetane
compound could obviously increase the chemiluminescent intensity48, that was further
demonstrated by Schaap and Gagnon. 49,50 According to this result, another group indicated that
chemiluminescence emission was significantly increased with the phenolic proton elimination
and intramolecular electron transfer from an electron rich group, such as a phenolate50. It was
found that the excited species could be produced by a back-electron transfer step, which released
the light emission in this process. In addition, the other energy transfer method of this excited
intermediate could be achieved, for example fluorescent dye could be regarded as energy
acceptor, which results in a fluorescent emission. The detailed process has been outlined with the
example of spiroadamantane-1,2-dioxetane47.(Scheme 2-7) Although many recent advances have
been obtained about 1,2 dioxetanes mechanistic studies, the exact mechanism of light emission
has not yet been well understood.
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Scheme 2-6 Examples of reaction-based detection strategies for hydrogen sulfide fluorescent
scaffolds.
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Figure 2-12 Some examples of 1,2-dioxetane chemiluminescent probes. (A) 1,2-dioxetane H2S
probes. (B) 1,2-dioxetane ONOO- probes. (C) 1,2-dioxetane HNO probe.
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Scheme 2-7 The catalyzed intramolecular decomposition process of spiroadamantane-1,2dioxetane.

2.1.4 Triggered 1,2-dioxeatne chemiluminescent probes
Triggerred 1,2-dioxetanes chemiluminescent probes were firstly reported by Schaap and his
coworkers in 198749,50. Later, the same group developed some other adamantane 1,2-dioxetane
derivatives containing masked phenolate groups and they found that chemiluminescence
emission can be triggered from the method of specific chemical deprotection of the phenolate
masking group. For example, chemiluminescence could be produced by converting tetra-butyl
ammonium fluoride to the tert-butylsilyl from a phenolate51. Later, the same group reported
other masking groups, such as acetate and phosphate52. These strategies of the phenolate
chemical decomposition provide the evidence of basic conception that efficient
chemiluminescence could be performed by using target molecule triggering the
chemiluminescent probes with high specificity.
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Scheme 2-8 1,2-Dioxetane derivatives with masked phenolate groups (MG = masking group).

In our previous research, we successfully synthesized and characterized adamantane 1,2dioxetane chemiluminescent probes CHS-1, CHS-2, and CHS-3, that used an azide trigger
strategy for the chemiluminescence detection of H2S53. The mechanism of this H2S mediated
azide reduction has been reported by the Pluth group54. This reaction is regarded as a first order
reaction for both reactants and hydrogen sulfide. Then chemiluminescence emission is triggered
upon the decomposition of this phenolate through CIEEL mechanism as Scheme 2-9.

Scheme 2-9 Chemically Induced Electron Exchange Luminescence (CIEEL) mechanisms of
spiroadamantane-1,2-dioxetane.
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Scheme 2-10 Mechanisms of spiroadamantane 1,2-dioxetanes (CHS-1, CHS-2, and CHS-3) for
H2S detection. (Adapted with permission from reference 53. Copyright 2015 RSC)

2.1.5 In vivo imaging
Based on the properties of reactive hydrogen and nitrogen species in previous research,
traditional methods for reactive hydrogen and nitrogen species detection are difficult to achieve
the real-time in vivo measurement with high sensitivity, including the methylene blue assay, high
performance liquid chromatography, mass spectrometry, electrochemical methods and so on 55,56.
Especially, many advanced reports of reaction-based chemiluminescent probes for H2S detection
have been performed in recent years, which enables us to detect H2S in living organisms with
higher sensitivity and selectivity.
As the advantages of chemiluminescence imaging, reaction-based chemiluminescent platform
could avoid some problems in fluorescence imaging, including autofluorescence, light scattering
and phototoxicity. Direct light generation from chemiluminescent molecules without any
external light source provides us with some unique advantages such as signaling the production
56

and intensity of the chemiluminescence emission. It is available for us to determine the presence
and concentration of the reactive species more accurately and provides a brilliant sensitive and
selective performance. Many reports about fluorescent and bioluminescent probes for living
animal imaging57,58 indicated that chemiluminescent probes also have widespread potential value
for in vivo imaging.

Figure 2-13 Imaging H2S in SCID/BALB-C mouse carcasses using CHS-3. (Adapted with
permission from reference 53. Copyright 2015 RSC)
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2.2 Research Objectives
In this project, according to the previous study about adamantane 1,2-dioxetane
chemiluminescent probes for H2S (CHS-1, CHS-2 and CHS-3), we designed and synthesized
two new chemiluminescent probes CHS-4 and CL-DNP and completed the measurements of
selectivity and sensitivity for in vitro and in vivo conditions. The purpose of new probes
synthesis in this project is to improve the quantum yield and selectivity in aqueous solution
compared with other CHS probes we made. Furthermore, that could help us understand the
CIEEL mechanisms clearly and demonstrate how much influence of probes with different trigger
and linker have. In this project, we reported that new probes made some excited performances in
imaging process with different substituted groups of trigger and linker. Also, we explored that
the experimental conditions would significantly affect the measurements results for H2S probes.
2.3 Results and Discussion
2.3.1 Synthesis of Chemiluminescent Hydrogen Sulfide probes CHS-4 and CL-DNP
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Scheme 2-11 Synthesis of probe precursor adamantane acrylonitrile phenol.

The synthesis of this precursor started with 2-chloro-3-methoxy benzaldehyde, that was
reacted with trimethyl orthoformate and p-toluenesulfonic acid in MeOH. The product
compound 2 was reacted with triethyl phosphite and boron trifluoride diethyl etherate in DCM to
obtain the diethyl methoxy phosphonate compound 3. Next step, n-butyllithium and 2adamantanone was added to compound 3 in anhydrous THF to yield the enol ether product
compound 4. An substitution reaction was obtained by reacting compound 4 with sodium
ethanethiolate and cesium carbonate in anhydrous DMF. The product 5 was treated with Niodosuccidimide (NIS) in toluene to yield iodophenol product (compound 6). Compound 6 was
then reacted with addition of methyl acrylate, tri(o-tolyl)-phosphine, palladium (II) acetate by
Heck reaction, which produce the important probe precursor compound 7, that was used for
combining with multiple group triggers for detecting H2S in the future.
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Scheme 2-12 Synthesis of CHS-4.

For doing the synthesis of CHS-4, we firstly synthesized the hydrogen sulfide azide trigger
reagents. The procedure started with 4-aminobenzyl alcohol (compound 8), which was first reacted
with sodium nitrite and sodium azide in HCl to yield compound 9. Then compound 10 was
obtained by adding p-toluenesulfonyl chloride and sodium hydroxide in DCM to compound 9.
After obtaining this azide trigger product, there was two steps from compound 6 for completing
the synthesis of CHS-4. First, the hydrogen sulfide azide trigger, compound 10, was reacted with
adamantane acrylonitrile phenol (compound 7) in DMF with potassium carbonate to yield
compound 11. Finally, CHS-4 (compound 12) was obtained through an ozone reaction, which was
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dissolving compound 11 in DCM and adding the triplet sensitizer methylene blue hydrate with
bubbling oxygen through and shining light. (Scheme 2-2)

Scheme 2-13 Synthesis of CL-DNP.

Compared with CHS-4, there is no need of doing the trigger synthesis for the synthesis of CLDNP firstly. The CL-DNP precursor, compound 13 was obtained through the addition of 2bromo-1,4-dinitrobenzene and potassium carbonate in DMF. Then CL-DNP was obtained
through the similar method as CHS-4, that achives the dioxetane reaction dissolving the scaffold
in DCM with adding methylene blue hydrate, bubbling oxygen and shining yellow light.

61

2.3.2 Response and selectivity of CHS-4 and CL-DNP

Figure 2-14 Hydrogen sulfide dose dependence in PBS buffer (pH=7.41). (A) Time scan for 20
μM CHS-4 and 0, 50, 100, 200, 400, 800, 1000 μM Na2S. (B) The integrated emission intensity
of the chemiluminescent response for CHS-4. (C) Selectivity test of 200 μM CHS-4 to the
indicated analytes from 0 to 20 min. All experiments were performed in 10 mM PBS (pH 7.4)
containing ≤ 1% DMSO. Error bars are ± S.D. (1. 1 mM Na2S 2. 10 mM GSH 3. 1 mM cystein
4. 1 mM Na2SO3 5. 1 mM H2O2 6. 1 mM NaClO 7. 1 mM NaNO3 8. t-BuOOH 9. 1 mM
H2S+10 mM GSH 10. blank)

Based on the other hydrogen sulfide chemiluminescent probes (CHS-1, 2 and 3)
measurements, the chemiluminescent response of CHS-4 was first tested using 20 μM probe
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solution and different concentration Na2S aqueous solution (0, 50, 100, 200, 400, 800, 1000 μM)
in PBS buffer (pH = 7.41). CHS-4 performed immediately light emission in this animal relevant
conditions with H2S dose dependence. After demonstrating the chemiluminescent response of
CHS-4, we next tested the selectivity of this probe for H2S against other biologically relevant
RSON species such as cysteine, glutathione, Na2SO3 and so on. The selectivity test was carried
out by treating 200 µM CHS-4 with different amount of RSON species in 10 mM PBS buffer
(pH 7.4). 10 mM reduced GSH, 1 mM L-cysteine and Hcy, and 1mM sulfite (SO32–), hydrogen
peroxide (H2O2), hypochlorite (OCl–), tert-butyl hydroperoxide (tBuOOH) were used for
evaluation. There is no significant luminescence intensity increase of the other species over the
blank control after 30 min test, which demonstrates that CHS-4 has good selectivity and
sensitivity for H2S detection in vitro.
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Figure 2-15 Hydrogen sulfide dose dependence in PBS buffer (pH=7.41). (A) Time scan for 20
μM CL-DNP and 0, 0.2, 1, 2, 4 mM NaHS. (B) The integrated emission intensity of the
chemiluminescent response for CL-DNP. (C) Selectivity test of 200 μM CL-DNP to the
indicated analytes from 0 to 20 min. All experiments were performed in 10 mM PBS (pH 7.4)
containing 5% DMSO. Error bars are ± S.D. (1. 1 mM Na2S 2. 10 mM GSH 3. 1 mM cystein 4. 1
mM Na2SO3 5. 1 mM H2O2 6. 1 mM NaClO 7. 1 mM NaNO3 8. t-BuOOH 9. 1 mM H2S+10 mM
GSH 10. blank)

The chemiluminescent response measurement for the other hydrogen sulfide probe CL-DNP
was also tested using 20 μM probe solution. According to Pluth’s report, CL-DNP probe has
better response performance and sensitivity with NaHS dose dependence compared with Na2S,
that is used for azide trigger probes. Therefore, different with CHS-4, we chose different
concentration NaHS aqueous solution as the H2S donor. Additionally, the response test
temperature for CL-DNP was also changed from room temperature to 37 °C and 5% DMSO was
added in test solvent. The result of its response performed well as CHS-4 in the proper
conditions with H2S dose dependence. Compared with CHS-4, dinitrophenyl probe displayed a
lower background emission and better sensitivity with H2S donor dose dependence. In the other
hand, we also tested selectivity of this probe for H2S against other biologically relevant RSON
species same as CHS-4. The selectivity test was carried out by treating 200 µM CHS-4 with
different amount of RSON species in 10 mM PBS buffer (pH 7.4). Same as CHS-4, CL-DNP
displayed strongest emission intensity compared with the other species over the blank control
after time scan. However, there was an obviously intensity increase of this probe detecting some
other reactive species such as L-cysteine, sulfite (SO32–) and hydrogen peroxide (H2O2), which
indicated that CL-DNP performed not really good selectivity of H2S as CHS-4.
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Figure 2-16 The chemiluminescent response of CHS-4 and CL-DNP in different conditions. (A)
Time scan for 20 μM CHS-4 and 0, 0.2, 1, 2, 4 mM NaHS in 10 mM PBS buffer (pH=7.41) with
5% DMSO at 37 °C. (B) Time scan for 20 μM CL-DNP and 0, 50, 100, 200, 400, 800, 1000 μM
Na2S in 10 mM PBS buffer (pH=7.41) with ≤ 1% DMSO at 25 °C.

An interesting result we found that the chemiluminescence response performed significant
changes when we switched testing condition of CHS-4 and CL-DNP each other. For CHS-4,
after using NaHS as hydrogen sulfide donor with 5% DMSO at 37 °C, the time scan curves
displayed lower sensitivity compared with the testing result in original condition. On the other
hand, there was almost no response for CL-DNP probe with Na2S solution at room temperature.
Compared with the results we reported before, the emission intensity strength and sensitivity had
an obvious decrease, which demonstrated that Na2S was not a proper H2S donor for CL-DNP
probe. According to the different chemiluminescent response performance, we concluded that
some important factors like reactive species donor, testing temperature and solvent would affect
the emission intensity for chemiluminescent probes with different triggers, for example the
azide-based probe CHS-4 and dinitrophenyl probe CL-DNP.
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2.3.3 Cell studies of CHS-4 and CL-DNP
Next, we applied our probes CHS-4 and CL-DNP to detect cellularly generated H2S in
human lung adenocarcinoma epithelial cells (A549) due to their robust luminescence emission
intensity in biologically condition. As the in vitro measurements. the luminescent intensity
increased with increasing concentration of H2S for both of CHS-4 and CL-DNP, demonstrating
that they were available to detect Na2S/NaHS sensitively in a multi-well plate reader format.
Detection of endogenous hydrogen sulfide in vivo was then tested in F-12K media with CHS4. The cells were first incubated with black, 0, 400, 800 and 1000 μM Na2S for 1 hour. Then the
cells were washed by PBS buffer to remove any extracellular Na2S and dead cells. Next, the cells
were treated with 20 μM CHS-4 and tested immediately with the plate reader at 37 °C. After
running for 4 h, the instantaneous luminescence emission figure was obtained with Na2S dose
dependence. The cellular study of CL-DNP probe had same protocols with CHS-4, including the
initial incubation, cells washing and play reader running steps. Different with CHS-4, different
concentration NaHS aqueous solution with 5% DMSO was added in culture before the
incubation step instead of Na2S solution. Compared with the luminescence response in vitro,
both of CHS-4 and CL-DNP performed similar sensitivity trends of H2S dose dependence and
the peak emissions occurred around 15 minutes. In the future direction, we would explore the
cellular toxicity of these two probes using MTT assay and combine it with the cellular response
results to find the proper experimental condition for in vivo tests.
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Figure 2-17 A549 cellular response for (A) 20 μM CHS-4 with 0, 400, 800 and 1000 μM Na2S.
(B) 20 μM CL-DNP with 0, 500 and 1000 μM NaHS. Nine technical replicates across three
biological replicates were performed using a Cytation 5 Bio Tek plate reader at 37 °C.

2.3.4 Conclusion
In this project, we reported two chemiluminescent probe CHS-4 and CL-DNP for hydrogen
sulfide detection. CHS-4 has better performance of chemiluminescence emission and selectivity
compared with CHS-1, 2 and 3 as adamantane azide trigger probe. CL-DNP is another
chemiluminescent probe for hydrogen sulfide with a novel trigger, dinitrophenyl. After obtaining
the same measurements with CHS-4, we demonstrate that there are some different
characterizations with trigger changing, including hydrogen sulfide donor species, solvent
system and experimental conditions. Cellular studies provide us robust evidence for exploring
these chemiluminescent probes potential approaches of in vivo imaging in the future.
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2.4 Experimental Section
2.4.1 General Materials and Methods
All reactions were performed in dried glassware under an atmosphere of dry N2. Silica gel P60
(SiliCycle) was used for column chromatography, and SiliCycle 60 F254 silica gel (precoated
sheets, 0.25 mm thick) was used for analytical thin layer chromatography. Plates were visualized
by fluorescence quenching under UV light or by staining with iodine. Other reagents were
purchased from Sigma-Aldrich (St. Louis, MO), Alfa Aesar (Ward Hill, MA), EMD Millipore
(Billerica, MA), Oakwood Chemical (West Columbia, SC), and Cayman Chemical (Ann Arbor,
MI) and used without further purification. 1H NMR and 13C NMR spectra for characterization of
new compounds and monitoring reactions were collected in CDCl3 (Cambridge Isotope
Laboratories, Cambridge, MA) on a JEOL 500 MHz spectrometer or Bruker 400 MHz
spectrometer in the Department of Chemistry at Southern Methodist University. All chemical
shifts are reported in the standard notation of parts per million using the peak of residual proton
signals of the deuterated solvent as an internal reference. Coupling constant units are in Hertz
(Hz). Splitting patterns are indicated as follows: br, broad; s, singlet; d, doublet; t, triplet; q,
quartet; m, multiplet; dd, doublet of doublets; dt, doublet of triplets. High resolution mass
spectroscopy was performed on a Shimadzu IT-TOF (ESI source) at the Shimadzu Center for
Advanced Analytical Chemistry at the University of Texas, Arlington. Low resolution mass
spectrometry was performed using an Advion ExpressionL CMS (ESI source) at Southern
Methodist University.
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2.4.2 Synthesis Procedure

2-chloro-1-(dimethoxymethyl)-3-methoxybenzene (2). 2-chloro-3-methoxybenzaldehyde (5.12
g, 29.2 mmol, 1.0 equiv.) was added to dry round-bottom flask, flushed with N2, and dissolved in
15 mL of anhydrous methanol. P-toluenesulfonic acid (0.511 g, 2.94 mmol, 0.1 equiv.) and
trimethyl orthoformate (3.1 mL, 29 mmol, 1.0 equiv.) were then added to the reaction mixture.
The reaction was carried out at room temperature and allowed to run for 24 hours under N2. After
reaction completion, the mixture was transferred to a separatory funnel and added 30 mL NaHCO3
in it. The organic layer was then eluted with 3 x 30 mL EtOAc. Finally, the organic layers were
collected and dried with Na2SO4. The residue was concentrated under reduced pressure. Column
chromatography (10:1 hexanes: EtOAc) yielded compound (2) (5.21 g, 24.0 mmol, 85%) as a
colorless oil. 1H NMR (500 MHz, CDCl3) δ 7.25 (s, 1H), 7.23 (s, 1H), 6.93 (d, 1H, J = 7 Hz ),
5.63 (s, 1H), 3.89 (s, 3H), 3.35 (s, 6H).

Diethyl ((2-chloro-3-methoxyphenyl)(methoxy)methyl)phosphonate (3). The acetal compound
(2) (6.51 g, 29.8 mmol, 1.00 equiv.) was added to an oven-dried round-bottom flask, flushed with
N2, then dissolved it with 10 mL anhydrous DCM. The mixture was then cooled to 0 °C in an ice
bath and stirred it for 15 min. Boron trifluoride diethyl etherate (3.93 mL, 30.8 mmol, 1.02 equiv.)
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was then added dropwise to the flask. Then triethyl phosphite (5.25 mL, 30.6 mmol, 1.01 equiv.)
was added dropwise to the mixture, and the reaction was stirred for 20 minutes at 0 °C. The
reaction mixture was then heated at 40 °C under refluxed for 2 hours while being monitored by
TLC. Upon completion, the reaction was cooled to room temperature and quenched with 30 mL
of saturated NH4Cl. After transferring to separated funnel, the organic layer was then eluted with
3 x 30 mL of EtOAc. Then the organic layers were combined and dried with Na2SO4, filtered, and
concentrated under reduced pressure. Column chromatography (10:1 hexanes: EtOAc) yielded
compound (3) (7.55 g, 23.2 mmol, 80 %) as a yellow oil. 1H NMR (500 MHz, CDCl3) δ 7.25 (s,
1H), 6.87 (s, 1H), 5.15 (d, 1H, J = 14 Hz), 4.13 – 3.90 (m, 5H), 3.87 (s, 3H), 3.30 (s, 3H), 2.00 (s,
1H).

(1r,3r,5R,7S)-2-((2-chloro-3-methoxyphenyl)(methoxy)methylene)adamantine

(4).

Compound (3) (1.02 g, 3.09 mmol, 1.00 equiv.) was added to an oven-dried round-bottom flask,
flushed with N2, and dissolved in 10 mL anhydrous THF. The temperature was then brought down
to –78 °C in a dry-ice with acetone bath. 2.5 M n-BuLi (1.51 mL, 3.72 mmol, 1.20 equiv.) was
then added slowly and dropwise over 10 minutes. Then 2-adamantanone (0.581 g, 3.73 mmol, 1.20
equiv.) was dissolved in 5 mL anhydrous THF in a separate round bottom flask and then added to
the reaction mixture. The temperature is then raised to 35 °C in an oil bath and stirred for 2 hours.
Subsequently, the temperature was raised to 90 °C and put under reflux for 1 hour. After reaction
completion, the reaction was cooled to room temperature and quenched with 30 mL of saturated
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NH4Cl. The mixture was transferred to a separatory funnel and the organic layer was eluted with
3 x 30 mL EtOAc. The combined organic layers were then dried with Na2SO4, filtered, and
concentrated under reduced pressure. Column chromatography (15: 1 hexanes: EtOAc) yielded
compound (4) (0.71 g, 2.15 mmol, 72 %) as an amber oil. 1H NMR (500 MHz, CDCl3) δ 7.18 (t,
1H, J = 17 Hz), 6.90 – 6.87 (m, 2H), 3.88 (s, 3H), 3.31 (s, 3H), 3.26 (s, 1H), 1.67 – 1.29 (m, 15H).

3-(((1r,3r,5R,7S)-adamantan-2-ylidene)(methoxy)methyl)-2-chlorophenol (5). The ether
compound (4) (13.1 g, 40.9 mmol, 1.00 equiv.) was added to a dry flask and flushed with N2 and
dissolved in 50 mL of anhydrous DMF. Sodium ethanethiolate (4.13 g, 49.1 mmol, 1.20 equiv.)
and cesium carbonate (33.1 g, 102 mmol, 2.40 equiv.) were then added to the flask. The
temperature was raised to 120 °C and stirred for 24 hours under reflux. The reaction was monitored
by TLC. After the completion of the reaction, the reaction was quenched with 200 mL saturated
NH4Cl. Then the reaction mixture was transferred to a separatory funnel, and the organic layer was
eluted with 3 x 200 mL of EtOAc. Then the organic layer was washed with 3 x 250 mL of brine.
The organic layers were combined and dried with Na2SO4, filtered, and concentrated under
reduced pressure. Column chromatography (5:1 hexanes:EtOAc) was used for purification to give
compound (5) (10.8 g, 35.1 mmol, 89%) as an off-white solid. 1H NMR (500 MHz, CDCl3) δ 7.04
(t, 1H, J = 14 Hz), 6.93 (d, 1H, J = 4 Hz), 6.71 (d, 1H, J = 6 Hz), 3.22 (s, 3H), 3.16 (s, 1H), 2.00
– 1.81 (m, 16H).
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3-(((1r,3r,5R,7S)-adamantan-2-ylidene)(methoxy)methyl)-2-chloro-6-iodophenol

(6).

Compound (5) (1.00g, 3.28 mmol, 1 equiv.) and N-iodosuccinimde (0.75 g, 3.3 mmol, 1.0 equiv.)
were added to a round-bottom flask, flushed with N2, and then dissolved in 20 mL of toluene. The
reaction was cooled to 0 °C in an ice bath for 20 minutes. The mixture color changes from light
orange to red. Upon completion, the reaction mixture was transferred to a separatory funnel and
washed with brine. Some sodium thiosulfate pentahydrate crystals were added to the separatory
funnel to quench any remaining iodine. After shaking the separatory funnel, there was a color
change from red to clear. If the color did not become clear, more crystals were added. The organic
layer was eluted with 3 x 30 mL of EtOAc. Then the organic layers were combined, dried with
Na2SO4, and concentrated under reduced pressure. For purification, the crude product was rinsed
multiple times with hexanes. A solid white powder crashed out giving compound (6) (0.41 g, 1.09
mmol, 28%). 1H NMR (500 MHz, CDCl3) δ 7.62 (d, 1H, J = 6 Hz), 6.63 (d, 1H, J = 6 Hz), 3.25
(s, 3H), 3.23 (s, 1H), 2.04 – 1.65 (m, 15H).

(E)-3-(4-(((1r,3r,5R,7S)-adamantan-2-ylidene)(methoxy)methyl)-3-chloro-2hydroxyphenyl)acrylonitrile (7). Compound (6) (0.22 g, 0.46 mmol, 1.00 equiv.) and palladium
(II) acetate (0.011 g, 0.046 mmol, 0.10 equiv.) were added to an oven-dried microwavable flask,
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flushed with N2, and dissolved in 1 mL of acetonitrile. Then acrylonitrile (0.11 mL, 1.4 mmol, 3.0
equiv.) and triethylamine (0.11 mL, 0.70 mmol, 1.50 equiv.) were added to the reaction mixture.
The flask was then capped and stirred in the microwave for 70 minutes at 120 °C. Upon
completion, the reaction was cooled to room temperature and quenched with 15 mL of NH4Cl and
transferred to a separatory funnel. The organic layer was then eluted with 3 x 20 mL of EtOAc.
The organic layers were then combined, dried with Na2SO4, filtered, and concentrated under
reduced pressure. Column chromatography (9:1 hexanes: EtOAc) yielded compound 7 (0.08 g,
0.24 mmol, 46 %) as a brown oil. 1H NMR (500 MHz, CDCl3) δ 7.54 (d, 1H, J = 14 Hz), 7.26 (d,
1H, J = 6 Hz), 6.83 (d, 1H, J = 8 Hz), 6.32 (s, 1H), 6.14 (d, 1H, J = 18 Hz), 3.30 (s, 3H), 3.24 (s,
1H), 2.01 – 1.17 (m, 15H).

(4-azidophenyl)methanol (9) 4-aminobenzyl alcohol (1.02 g, 8.1 mmol, 1.0 equiv) was dissolved
in 20 mL 10% HCl solution in a round bottom flask under N2 atmosphere and cooled to 0 °C.
Sodium nitrite (0.68 g, 9.75 mmol, 1.2 equiv.) was dissolved in 10 mL water, added slowly and
dropwise, and allowed to stir for 30 min. Then sodium azide (0.83 g, 9.75 mmol, 1.2 equiv.) was
dissolved in 10 mL water, added slowly and dropwise, and stirred for an additional 2 hrs. The
reaction was monitored by TLC. Upon completion, the reaction was transferred into a separatory
funnel, washed with brine, eluted with 3 x 50 mL EtOAc. The combined organic layer was dried
with Na2SO4, filtered, and concentrated under reduced pressure. Purification by column
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chromatography (5:1 hexanes:EtOAc) yielded compound 9 (1.10 g, 6.82 mmol, 87%). 1H NMR
(400 MHz, CDCl3) δ 7.39 (d, 2H, J = 20 Hz), 7.01 (d, 2H, J = 18 Hz), 4.67 (s, 2H), 1.91 (s, 1H).

(E)-3-(4-(((1r,3r,5R,7S)-adamantan-2-ylidene)(methoxy)methyl)-2-((4-azidobenzyl)oxy)- 3chlorophenyl)acrylonitrile. (11) The precursor phenol, compound (6) (0.04 g, 0.11 mmol, 1
equiv.) was dissolved in 3 mL anhydrous THF under a N2 atmosphere and cooled to 0°C.
Compound 7 (0.016 g, 0.10 mmol, 1 equiv.) and triphenylphosphine (0.036 g, 0.12 mmol, 1.2
equiv.) were added to the reaction mixture and allowed to cool for 5 min. Then DEAD (0.02 mL,
0.1 mmol, 1.2 equiv.) was added and stirred for 1 hr while being monitored by TLC. Upon
completion, the reaction was transferred to a separatory funnel and quenched with sat. NH4Cl. The
organic layer was eluted with 3 x 25 mL EtOAc, dried with Na2SO4, filtered, and concentrated
under reduced pressure. Column chromatography (10:1 hexanes:EtOAc) yielded (10.4 mg, 0.36
mmol, 33%). 1H NMR (400 MHz, CDCl3) δ 7.55 (d, 1H, J = 14 Hz), 7.41 (d, 4H, J = 20 Hz), 7.32
(d, 2H, J = 20 Hz), 7.16 – 7.02 (m, 5H), 5.92 (d, 2H, J = 14 Hz), 5.44 (s, 1H), 4.99 (s, 3H), 4.54 –
4.53 (m, 2H), 3.34 (s, 3H), 3.31 (s, 1H), 2.20 – 0.92 (m, 21H).

(E)-3-(2-((4-azidobenzyl)oxy)-3-chloro-4-((1r,3r,5r,7r)-4'-methoxyspiro[adamantane-2,3'[1,2]dioxetan]-4'-yl)phenyl)acrylonitrile (CHS-4). Compound 11 (10.2 mg, 0.02 mmol, 1
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equiv.) and methylene blue hydrate (8 mg, 0.02 mmol, 1 equiv.) were added to a dry flask and
dissolved in 2 mL DCM. Oxygen was bubbled through the reaction mixture, while irradiating with
a 120 W light bulb (Home Depot, Dallas, TX) at 0 °C. After 1.5 hours, TLC indicated no starting
material remained, the reaction mixture was concentrated under reduced pressure. The product
was purified by column chromatography (8:1 hexanes:EtOAc) yielding compound CHS-4 (6.8
mg, 0.01 mmol, 51%). 1H NMR (400 MHz, CDCl3) δ 7.98 (d, 1H, J = 13 Hz), 7.53 (s, 1H), 7.49
(s, 1H), 7.44 (d, 2H, J = 6 Hz), 7.08 (d, 2H, J = 4 Hz), 5.96 (d, 1H, J = 18 Hz), 5.02 (s, 1H), 4.96
(s, 2H), 3.26 (s, 3H), 3.07 (s, 1H), 2.17 – 0.90 (m, 20H).

(E)-3-(2-((4-dinitrophenyl)oxy)-3-chloro-4-((1r,3r,5r,7r)-4'-methoxyspiro[adamantane-2,3'[1,2]dioxetan]-4'-yl)phenyl)acrylonitrile (CL-DNP). Compound 6 (103 mg, 0.28 mmol, 1.0
equiv.) was dissolved in 5 mL anhydrous DMF with addition of 2,4-dinitrobromobenzene (74 mg,
0.29 mmol, 1.0 equiv.) and potassium carbonate (80 mg, 0.57 mmol, 2.0 equiv.). The reaction
mixture was then stirred under N2 for 24 h at room temperature. After completion, the reaction
was quenched with 5 mL brine and extracted with 3 x 10 mL EtOAc. The organic layer was washed
with 3 x 10 mL 5% aqueous LiCl and dried Na2SO4, filtered, and concentrated under reduced
pressure. The product was purified by column chromatography (2:1 hexanes:EtOAc) to yielding
compound 13 110 mg of white solid. This enol ether product (10.4 mg, 0.02 mmol, 1.0 equiv.) was
then added to a round-bottom flask and dissolved in 15 mL DCM with addition of methylene blue
hydrate (4 mg, 0.01 mmol, 0.5 equiv.). Oxygen was bubbled through the reaction mixture, while
irradiating with a 120 W light bulb (Home Depot, Dallas, TX) at 0 °C. After 1.5 hours, TLC
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indicated no starting material remained, the reaction mixture was concentrated under reduced
pressure. The product was purified by column chromatography (1:1 Hexane: EtOH) to yield CLDNP (9.8 mg, 0.018 mmol, 77%). 1H NMR (500 MHz, CDCl3) δ 8.93 (d, 1H, J = 2.8 Hz), δ 8.24
(bs, 1H), 8.23 (d, 1H, J = 7.8 Hz), 7.70 (d, 1H, J = 7.4 Hz), 7.50 (d, 1H, J = 14.8 Hz), 6.48 (bs,
1H), 6.16 (d, 1H, J = 14.8 Hz), 3.25 (s, 3H), 3.06 (s, 1H), 2.09 – 1.08 (m, 14H).

2.4.3 Chemiluminescent response
The chemiluminescent response and time scans of CHS-4 were obtained with a Cytation 5 Bio
Tek plate reader using the luminescence detection method under room temperature (25°C). A 5
mM stock solution of each probe was diluted to a 20 μM before testing. A 50 mM stock solution
of Na2S was prepared and diluted to the final concentration of 0, 50, 100, 200, 400, 800, 1000 μM.
Time scans were obtained immediately following adding the reagents, including PBS buffer,
probe, and Na2S.
The chemiluminescent response and time scans of CL-DNP were obtained with a Cytation 5
Bio Tek plate reader using the luminescence detection method at 37 °C. A 5 mM stock solution of
each probe was used with a 20 μM final concentration. A 50 mM stock solution of NaHS was
prepared for each experiment and diluted to the final concentration to 0, 0.2, 1, 2, 4 mM. Time
scans were obtained immediately following adding the reagents, including PBS buffer, probe, and
NaHS.
2.4.4 Selectivity tests
Selectivity for CHS-4 and CL-DNP was measured by monitoring the time-dependent
chemiluminescence emission at 545 nm. All assays were performed in 10 mM PBS buffered to
pH 7.4.
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H2S: 5 µL of a 20 mM stock solution of Na2S/NaHS in DI-H2O was added to a solution of 393
µL PBS and then 2 µL of 10 mM CHS-4/CL-DNP in DMSO was added into this mixture.
GSH: 25 µL of a 100 mM stock solution of GSH in 20 mM HEPES buffer was added to a
solution of 373 µL PBS and then 2 µL of 10 mM CHS-4/CL-DNP in DMSO was added into this
mixture.
Cysteine: 5 µL of a 100 mM stock solution of L-cysteine in DI-H2O was added to a solution of
393 µL PBS and then 2 µL of 10 mM CHS-4/CL-DNP in DMSO was added into this mixture.
NaNO2: 1 µL of a 100 mM stock solution of NaNO2 in DI-H2O was added to a solution of 397
µL PBS and then 2 µL of 10 mM CHS-4/CL-DNP in DMSO was added into this mixture.
Na2SO3: 1 µL of a 100 mM stock solution of Na2SO3 in DI-H2O was added to a solution of 397
µL PBS and then 2 µL of 10 mM CHS-4/CL-DNP in DMSO was added into this mixture.
H2O2: 0.5 µL of a 200 mM stock solution of H2O2 in DI-H2O was added to a solution of 397.5 µL
PBS and then 2 µL of 10 mM CHS-4/CL-DNP in DMSO was added into this mixture.
OCl–: 1 µL of a 100 mM stock solution of OCl– in DI-H2O was added to a solution of 397 µL
PBS and then 2 µL of 10 mM CHS-4/CL-DNP in DMSO was added into this mixture.
t

BuOOH: 1 µL of a 100 mM stock solution of tBuOOH in DI-H2O was added to a solution of 397

µL PBS and then 2 µL of 10 mM CHS-4/CL-DNP in DMSO was added into this mixture.
Blank: 2 µL of 10 mM CHS-4/CL-DNP in CH3CN was added to a solution of 398 µL PBS
buffer.
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2.4.5 Cellular Experiments
Human lung adenocarcinoma epithelial cells (A549) were purchased from ATCC. The cells were
cultured in Ham’s F-12K (Kaighn’s) medium with 10% Fetal Bovine Serum (FBS) and 1%
antibiotics (penicillin/streptomycin, 100 U/mL). Cells were kept in a humidified incubator at 37
°C with 5% CO2. One or two days before a cellular experiment was conducted, cells were plated
onto a sterile multi-well plate and allowed to reach a confluence of 80–95% by the time of
testing. All chemiluminescent responses for cellular testing were obtained using the Cytation 5
Bio Tek plate reader (Winooski, VT) at 37 °C.
Stock solutions of 20 mM Na2S/NaHS were prepared in DI-H2O and 10 mM CHS-4/CL-DNP
was prepared in DMSO. According to the H2S dose dependence, 2 µL probe stoke solutions and
different volume Na2S/NaHS stoke solutions were added in every well. After another 40 min
incubation, cells were washed with 2 x PBS. Then 500 µL PBS media was added into each well
and the luminescent intensity was measured every five minutes for 240 minutes. The experiment
was repeated with three independent well plates and the peak value for the luminescence
emission for each well at 12–15 minutes was normalized to the average luminescence emission
at 12–15 minutes for the control replicates of each plate. A single outlier was rejected according
to the extreme studentized deviate method (p < 0.01).
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CHAPTER 3
CELLULAR STUDIES OF VARIOUS FLUORESCENT COMPOUNDS
3.1 Introduction
Besides the chemiluminescent probes research, more cellular studies of other compounds are
obtained, including LIVE/DEAD assay, photothermal experiments, and cells imaging with
luminescent nanoclusters. First, we cooperated with Dr. Watkins (Associate Professor from
University of Mississippi) for an interesting project named “Crosslinking PCL-PAMAM Linear
Dendritic Block Copolymers (LDBC) for Theranostic Nanomedicine”. In this project, we
completed the in vitro photothermal tests, which determined how much toxicity of nanoparticle
treatment and irradiation time for A549 cells was. Additionally, another project “Visible Light
Chemical Micropatterning Using a Digital Light Processing Fluorescence Microscope” in our
group was completed last year and cell labelling experiments of photoluminescent dyes was
displayed using visible light mediated chemistry and the DLP microscope. Furthermore, we
attempted the Cy5 and Dapi cellular imaging for a series of metal organic polymer clusters with
Dr. Das (Assistant Professor from SMU). In this project, we explored these clusters and
performed characterizations such as emission intensity and phototoxicity could be affected by
cell culture and incubation time.
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3.2 Photothermal cellular test of LDBC
In this study, Dr. Watkins group designed and synthesized novel nanoparticles formed from
LDBC.1,2,3 This crosslinked nanoparticle demonstrated a significant increase of hydrophobic
loading efficiency.4,5,6 In addition, when nanoparticles loaded with a potential photothermal
agent (C5), a high photothermal efficiency was performed. In cells studies, these nanoparticles
performed efficiently into HEK293 cells with proper condition. Our group supported another
cellular phototoxicity test for exploring the relationship between illumination with red light and
cell death in A549 cells.

Figure 3-18 Graphical representation of PhPCL-G3 LDBCs forming polymersome-like
nanoparticles in water via physical core-crosslinking induced by π – π interactions. (Adapted
with permission from reference 37. Copyright 2022 ACS)
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3.2.1 Photothermal Efficiency
The photothermal efficiency described the property of the dispersion temperature increase of
nanoparticle upon irradiation with an 808 nm laser.7,8 The photothermal efficiency, 𝜂 , was
calculated by:

𝜂=

ℎ𝐴(Δ𝑇𝑚𝑎𝑥 − Δ𝑇𝑠𝑜𝑙 )
𝐼(1 − 10−𝐴𝜆 )

where ℎ is the heat transfer coefficient, 𝐴 is the surface area of the container, Δ𝑇𝑚𝑎𝑥 is the
maximum temperature change of the dispersion, Δ𝑇𝑠𝑜𝑙 is the maximum temperature change for the
negative control MilliQ water under same condition, 𝐼 is the laser irradiation power and 𝐴𝜆 is the
absorbance of nanoparticles with photothermal agents at this light condition. After the irradiation
with a visible light irradiation, these nanoparticles performed an obvious increase the temperature
of the system from 21.6 °C to 66 °C in 20 minutes.
Table 3-5 Photothermal efficiency calculations37
ℎ𝐴
Sample

𝛥𝑇𝑚𝑎𝑥

𝛥𝑇𝑠𝑜𝑙

𝑚𝑐𝑝
(J/K)

(K)

(K)

48.2% 0.011119 376.43

4.1855

43.4

2.2

0.95

45.7% 0.010749 389.4

4.1855

42.6

2.2

0.95

𝜂

𝑘𝑡~
ℎ𝐴
(s)

C5PhPCL
ICGPhPCL
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𝐼 (J/sec)

𝐴𝜆
(estimated)
9.555589
27.17803

Figure 3-19 (A) Dispersion of C5 in water; (B) C5 loaded 10-PhPCL-G3 (C) photothermal
activity of PhPCL-G3 nanoparticles. (Adapted with permission from reference 37. Copyright
2022 ACS)

3.2.2 Nanoparticles in Biological Imaging and Phototherapy
Additionally, we designed and completed the cellular imaging and phototoxicity tests of C5loaded nanoparticles in human lung cancer (A549) cells. According to the properties of this
nanoparticles, we designed two experiments by treating cells with different concentrations of the
nanoparticle and different irradiation time with 100W red LED lamp. Compared to cells treated
with two negative controls (no dye-loaded nanoparticle and no light irradiation) (Figure 3-20),
positive samples indicate an obvious increase in cell death after irradiation and increase with time
(Figure 3-21). As the figure shows, the difference in the number of dead cells versus live cells
(red versus green) was related to nanoparticle treatment and irradiation time, which performed a
close relationship with increasing illumination time, and provide valuable evidence for using these
nanoparticles for in vivo experiments in the future.9,10
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Figure 3-20 Representative trial experiments: cells treated with varying concentrations of the
nanoparticle suspension where either irradiated with a 100W red LED lamp for 0, 8, or 80
mins.37 (Adapted with permission from reference 37. Copyright 2022 ACS)
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Figure 3-21 Quantified cell death upon irradiation time (x-axis concentration, y-axis dead cell
%); cell death % determined as 100 x (Red/(Red+Green)) n = 4 technical replicates across 2
independent experiments error bars are SD; 0, 8, 80 = minutes. (Adapted with permission from
reference 37. Copyright 2022 ACS)

3.2.3 Experimental Section
In this project, our group mainly focused on the in vitro photothermal assay,11,12 that used Human
lung cancer (A549) cells for it. A549 cells were prepared in three 12-wells plates and grown at 37
°C, 5% CO2, F-12K media with 10% FBS. After the confluency reaching around 90%, cells were
washed with 10 mM PBS buffer for three times and treated with different concentrations of
polymers in 1 mL cells media. Then the cells were incubated overnight under 5% CO2 at 37 °C.
After that, one plate of cells was placed in the dark for 8 min, the other two plate cells were
irradiated with the red LED (100W RGB LED Flood Light), one for 8 min and the other one for
80 min, followed by incubation for 2 h. The light intensity was measured with a ThorLabs digital
light meter and sensor and was found to be 9.7 ± 2.9 mW/ cm2. After incubation, cells of each well
were washed with 10 mL PBS buffer and then 200 mL LIVE/DEAD Cell Imaging assay solution

88

was added in every well. Cell death was evaluated with a LIVE/DEAD Cell Imaging KitTM
Invitrogen following the manufacturer’s protocols, that was evaluated by counting the live cells
indicated by green fluorescence and the dead cells indicated by red fluorescence (GFP filter cube:
470/22 nm excitation, 525/50 nm emission. RFP filter cube: 531/40 nm excitation, 593/40 nm
emission) using an EVOS-fl fluorescence microscope.
3.2.4 Coclusions
In this project, Watkins group successfully synthesized crosslinking LDBC nanoparticles and
analyze some important characterizations about loading efficiency and photothermal stability. It’s
my pleasure to participate and complete the photothermal experiments for this project. As the
results of LIVE/DEAD assay, C5-loaded nanoparticles were able to cause cell death in cancer cells
under exposure to red light irradiation. This photothermal test results provided us valuable
evidence for improving the potential of LDBCs in phototherapy applications.
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3.3 Visible Light Chemical Micropatterning Using DLP
High-resolution patterning chemical reactivity13 plays an important role in advanced area
including nanorobotics14, bioprinting15, and photopharmacology16. It’s necessary for us to develop
novel techniques that could be widely used and compatible with various chemical properties. Our
group reports the development of a digital light processing (DLP) fluorescence microscope that
could achieve structuring of visible light (465–625 nm) for high-resolution photochemical
patterning and fluorescence imaging17. Visible light photochemical systems can be performed by
various specific reactions, such as thiol-ene photoclicking18 and Wolff rearrangements of
diazoketones19. Therefore, we designed and achieved the patterning of this functional chemical
reaction onto microscopic polymer beads and films21,22. Also, target labelling in living cells is
demonstrated by photoactivation of RhBNN. That could help us explore new approaches for novel
areas such as 3D printing and new generation nanorobots.
3.3.1 DLP Microscope Design and Fabrication
For achieving high-resolution photochemical imaging, we designed and projected a digital light
processing (DLP) fluorescence microscope for projecting patterned visible light with microscale
substrates and fluorescence imaging (in chapter 1). DLP system was accomplished using a digital
micromirror and projection device in the LightCrafter 4500 with the projection optics removed
(Texas Instruments, USA). (Figure 3-22)
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Figure 3-22 (A) Design scheme and (B) photograph of the DLP microscope setup composed of:
1. DLP LightCrafter 4500 as the patterned light source, 2. An adjustable iris diaphragm, 3. A
mounted achromatic doublet collimation lens with 100 mm focal length, 4. Zoom housing with
4.1 mm linear travel, 5. A 650 nm shortpass excitation filter, 6. A 660 nm dichroic beamsplitter,
7. Zoom housing with 4.1 mm linear travel, 8. A 4x objective (0.10 NA, 18.5 mm WD), a 40x
objective (0.60 NA, 1.2 mm WD), or a 100x oil objective (1.30 NA, 0.17 mm WD), 9. An XY
translational stage, rigid stand, and slide holder, 10. A 692/40 nm bandpass emission filter, 11.
A mounted achromatic doublet lens with 100 mm focal length and 2.5” lens tube, and 12.
Chameleon3 Monochrome sCMOS camera. (C) Checkerboard pattern and one-pixel width
diagonal lines projected onto a target resolution slide using 4x, 40x, and 100x objectives. Inset:
projection resolution determined as the FWHM of the Gaussian fit to imaged pixel intensities
across a projected one-pixel line. Error on FWHM is ± S.D. with n = 3 different lines measured.
(Adapted with permission from reference 36. Copyright 2021 ACS)
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3.3.2 Visible Light Mediated Reaction
In this study, thiol-ene photoclick reaction was investigated and initiated by a visible light
photoinitiator24,25, which has some specific photochemical properties. According to it, our group
developed and synthesized some observable thiol covalent modification containing polymer
constructs, that were combined with the fluorescent silicon rhodamine. Thiol-ene reactions was
reported in previous studies last decades, that was useful to accomplish photochemistry
patterning26. Based on it, we firstly prepared the fluorescent silicon rhodamine-styrene (SiR-sty)
as alkene reaction partner, that increased fluorescence by achieving thiol-ene ligation on the SHresin beads. The reactant SiR was synthesized by using the silicon anthrone and tert-butyl
protected 3-iodo-4-methylbenzoic acid with n-butyllithium, and the thiol-ene partner SiR-sty was
yielded with an amide coupling of SiR with 4-amino styrene. The other part of thiol-ene reaction,
SH-resin was obtained by coupling the amino resin with fmoc- and mmt- protected cysteine, then
deprotected the mmt-cysteine group with 1% trifluoroacetic acid. Finally, the thiol-modified SHresin was reacted with SiR-sty and eosin y in DMSO under blue light irradiation overnight. As the
results in Scheme 3-16, strong fluorescence emission from beads was observed when the reaction
was irradiated under blue light. In the other hand, there was extreme weak emission observed when
the reaction was conducted in the dark.
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Scheme 3-14 Examples of thiol-ene reaction with eosin y.

Scheme 3-15 Synthesis of fluorophore-tagged alkene, SiR-sty. (Adapted with permission from
reference 36. Copyright 2021 ACS)
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Scheme 3-16 Reaction scheme and EVOS-fl fluorescence images (Ex: 635/18 Em: 692/40) of
washed SH-resin beads after reacting in a solution of 3mM SiR-sty and 70 µM eosin y in DMSO
for 22h with and without blue light irradiation from a 100 W LED lamp at 0.04 W cm−2.
(Adapted with permission from reference 36. Copyright 2021 ACS)

Besides that, we designed another fluorescent probe that could achieving for photochemical
patterning with diazo compounds, Rhodamine B based photocaged dye RhBNN27,28. When the
diazoketone group on RhBNN is irradiated with blue light, a carbene is generated, which could
form a ketene intermediate immediately by Wolff rearrangement. Then the ketene could be reacted
with nucleophilic species such as alcohols29 and amines30, that performs strong fluorescence
emission of rhodamine B. In this study, we irradiated polyvinylalcohol (PVA)31 films containing
50 µm Rhodamine BNN (RhBNN-PVA) covered by glass microscope slides with blue light. After
22 hours irradiation, the films performed strong red fluorescence compared to those that were kept
in the dark condition (Scheme 3-17).
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Scheme 3-17 Reaction scheme and EVOS-fl fluorescence images (Ex: 542/20 Em: 593/40) of
PVA films doped with 20 µM Rhodamine BNN with and without 22 h blue light irradiation from
a 100 W LED lamp at 0.04 W cm−2. (Adapted with permission from reference 36. Copyright
2021 ACS)

3.3.3 RhBNN Patterned Labelling of Living Cells
Next, based on the DLP microscope and Rhodamine B insertion studies, we attempted visible
light driven targeted labelling experiment of live cells with RhBNN. We incubated A549 cells in
T25 cell culture flasks with 20 µM RhBNN in PBS buffer and 2% DMSO for 30 mins for uptake.
After washing the cells with PBS buffer, the cells were displayed on the DLP microscope and
irradiated with blue light in the split field pattern. After bule light irradiation, the fluorescence
emission of cells was performed by using green light at time points from 0–30 seconds (Figure 323). The result confirmed that cells displayed obvious stronger fluorescence emission with
increasing irradiation time on the irradiated field. Compared to it, cells with no blue light on the
right side of the field remained non-fluorescent, which demonstrated that living cells can be
accurately labelled and selectively functionalized with fluorescent dye using RhBNN patterning
chemistry and the DLP microscope.
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Figure 3-23 DLP Micropatterning of live A549 cells using visible light. (A) DLP fluorescence
image of cells incubated for 30 mins with 20 µM RhBNN under a 40x objective before blue light
irradiation and (B) after 30 s irradiation with blue light at 9.4 W cm−2 with a split field pattern
which irradiates the left half of the field. (C) Plot of average pixel intensities of all cells in
irradiated and non-irradiated half of field with increasing irradiation times. Error bars are ± S.D.
with n = 3 independent replicates. Images A,B are displayed with equally brightness and
contrast; raw images available in ESI. (Adapted with permission from reference 36. Copyright
2021 ACS)

3.3.4 Experimental Section
In cellular experiments, cells were passaged by seeding in T25 cell culture flasks
(Falcon,29185-298) and covering with 5.0mL of media. These experimental flasks were allowed
to grow for 2 to 3 days, or until they had reached between 70% and 90% confluence. A 1mM
RhBNN stock solution in DMSO was prepared by dissolving 3.4 mg RhBNN into 6.0 mL
DMSO and stored in a foil-wrapped scintillation vial. To each flask of confluent cells, 50μL of
RhBNN stock solution was added to the T25 flask without replacement or removal of media
(final concentration:10 μM RhBNN,1% DMSO). The flasks were gently agitated, and then
allowed to incubate for 30 min to uptake the RhBNN. Medium was then removed, and cells were
washed with 2x5 mL PBS buffer to remove any RhBNN not uptaken by the live cells. The cells
were submersed in PBS for micropatterning experiments.
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A549 cells were incubated with RhBNN and prepared for imaging as described above. A field
of cells was focused under a 40x objective and imaged under uniform green light (2.8W cm−2)
prior to patterning. Using the Parallel RGB input of the Light Crafter 4500, the coordinates of the
desired cell were mapped onto a PowerPoint slide, where a white square was placed on top of a
black background to illuminate one and only one cell. The cells were irradiated with this
powerpoint slide for 0s, 30s, 60s, and 90s with high intensity blue light (9.4W cm−2) and imaged
under weak green light (2.8W cm−2). The selected cell that was irradiated showed a significant
increase in fluorescent intensity, whereas cells not irradiated showed no significant increase in
fluorescent intensity.
3.3.5 Conclusion
In summary, we design a chemical micropatterning technique using digital light processing
fluorescence microscope (DLP) and photochemical reaction systems. Based on it, visible-light
based thiol-ene reactions and diazoketone Wolff rearrangements of silicon rhodamine and
rhodamine BNN onto solid resin beads and PVA films were achieved by this technology with
high resolution. In addition, DLP micropatterning was performed for fluorescent labelling of
selected single live cells, which demonstrated a significant potential for using in a wide range of
applications like metamaterials.

97

3.4 Generation of fluorescent Aun(Sdam)n Nanoclusters
Metal nanoclusters are novel compounds which have small size and special properties
governed by their sub-nanometer dimensions.32 As a representative class of polymers, metal
nanoclusters have some advantages and unique fluorescent and luminescent properties compared
with other polymers. Additionally, metal nanoclusters have better performance for labeling and
imaging applications in vivo compared with some molecules which have larger size and toxic metal
species such as cadmium and lead.33,34 Hererin, Dr. Das and her group designed and several novel
gold nanoclusters with multiple ligands that demonstrated excited photochemical properties. Next,
we completed some cellular experiments in A549 cells including EVO-fi imaging and cluster toxicity
test. These results provide valuable evidence for deeply understanding the characterizations of noble
metal nanoclusters and developing the photoexcitation process of single oxygen production in the
future.

3.4.1 Au2Ag6(dppm)2(Sdam)6 nanocluster
In this study, the noble metal nanocluster is designed as Figure 3-24, which is combined with
gold and silver as center, dppm and Sdam as ligands. Dr. Das group successfully synthesized it
and completed some photochemical measurements such as absorption and emission spectrum,
quantum yield and so on. (Figure 3-25) According to these results, we continued to be setting up
several in vivo experiments for confirming the fluorescence emission imaging and cellular
toxicity.
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Figure 3-24 Crystal structure of Au2Ag6 (Ph3P-CH2-PPh3)2(SR) (SR=1-Adamantanethiol
(C10H16S), tert-Butylthiol) (Allowed to use by Dr. Das group)

Figure 3-25 (A) Absorption spectrum of T sample-1 and T-sample 2. (B) Emission under 365
nm UV light of T sample-1 and T sample-2 in solid and solution state. (Allowed to use by Dr.
Das group)
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To confirm the biocompatibility and photodynamic activity of Au2Ag6(dppm)2(Sdam)6
nanocluster toward cancer cells, we investigated the capability of the cluster to reduce the
viability of cancer cells. Before applying Au2Ag6(dppm)2(Sdam)6 for the photodynamic killing
of cancer cells, the cellular imaging and cytocompatibility of Au2Ag6(dppm)2(Sdam)6 was first
examined using EVO-fi microscope and MTT assay.As shown in Figure 3-26, upon incubation
with Au2Ag6(dppm)2(Sdam)6, the cellular viability of A549 cells remained above ∼70% in the
range of 1−25 μM nanocluster for 1 h. With the concentration increasing above 50 μM, the
cellular viability decreased to 30-40% immediately. As shown in Figure 3-27, the fluorescence
imaging of Au2Ag6(dppm)2(Sdam)6 with 1-100 μM was performed after 1 h incubation. Also,
combining with the nuclear localization test, the mean pixel average was showed a clear trend
with concentration dependence. It’s meaningful for us to develop more applications such as
singlet oxygen photoexcitation in the future.

Figure 3-26 MTT assay of A549 cells in the presence of different concentrations of T-sample 2.
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Figure 2-27 Cellular imaging of T-sample 2 by EVO-fi microscope.

3.4.2 Au2Cu6(F-phosphine)2(Sdam)6 nanocluster
In addition, for deeply understanding the properties of these gold nanoclusters, Dr. Das group
also synthesized other compounds to be characterized, for example Au2Cu6(Fphosphine)2(Sdam)6. Compared with the gold-silver cluster, this molecule used F-phosphine as
ligands instead of dppm, which could bond with metal anions center. As the experiments of
Au2Ag6(dppm)2(Sdam)6, cellular imaging and viability tests were completed with the same
condition (final concentration of sample is in the range of 0-100 μM). Interestingly, the
fluorescence cellular imaging of Au2Cu6(F-phosphine)2(Sdam)6 with 25-50 μM was performed
well after 1 h incubation. However, we found that the cell toxicity would increase obviously with
above 50 μM cluster, which was also confirmed by cell viability experiment using MTT assay.
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3.4.3 Experimental Section
Cellular fluorescence imaging. A549 cells were prepared in three 12-wells plates and grown
under standard conditions (37 °C, 5% CO2, F-12K media with 10% FBS). A549 cells were washed
with 10 mM PBS buffer and treated with 0 (A1-A2), 10 μM (B1-B3), 25 μM (C1-C3), 50 μM (D1D3) polymers in 1 mL F-12K media. The cells were incubated for 1 h under 5% CO2 at 37 °C.
Then 50 μL nuclear localization assay solution was added into the cell culture. Plates were put in
the dark condition for 30 mins. After incubation, the culture media of each well was removed and
200 mL 10 mL PBS buffer was added to each well. After washing out, the cells were indicated by
red fluorescence (Cy5 filter cube: 531/40 nm excitation, 593/40 nm emission) and the cells nuclear
indicated by blue fluorescence (Dapi filter cube: 357/44 nm excitation, 447/60 nm emission) using
an EVOS-fl fluorescence microscope. Two independent experiments were performed to assure
consistency. Statistical significance between dark control and 8 min irradiation test and statistical
significance between dark control and 80 min irradiation test were calculated using a two-tailed
Student’s t-test with n = 4 technical replicates across two independent experiments.
Cell viability test. RAW 264.7 macrophage cells (106 cell/mL) were seeded in a 12-well plate to
a total volume of 1 mL/well. The plate was maintained at 37 °C with 5% CO2 for 12 h. Cells
were then incubated for 1 h after adding different concentrations of nanocluster, 0, 1, 10, 100 and
1000 µM respectively. 50 µL of the MTT reagent (Cayman Chemical, Ann Arbor, MI) was then
added to each well, and mixed gently. After 4 h incubation, 100 µL of crystal dissolving solution
was added to each well to dissolve the formazan crystals. Absorbance was measured at 570 nm
in a Cytation 5 BioTek plate reader, that was used to calculate the cell viability percentage.
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3.4.4 Prospective research
According to the promising results we have, some photoexcited study can be explored in the next
step such as singlet oxygen generation. In recent advanced research, singlet oxygen can be
efficiently produced upon the direct photosensitization by gold nanoclusters without any
conventional photosensitizers under visible/near-IR irradiation.35 Based on it, we could develop
the new clusters potential of 1O2 generation using the multiple adamantane chemiluminescent
probes as detector. In the future, this series of nanoclusters will be investigated for their potential
use in targeting, imaging and other applications, where the organic-soluble or water-soluble
clusters perform promise as heterogeneous 1O2 catalysts in chemical reactions.
3.5 Summary
Cellular study is a meaningful and important part in the research of luminescent compounds.
There are various in vivo experiments, including fluorescence imaging, chemiluminescence
detection, photochemical properties measurements and so on. In this dissertation, we completed
several cellular tests for different photochemical molecules. These experiments provide us more
evidence to demonstrate the spectroscopy results of in vitro measurements. Furthermore, there
are large potential use for developing more applications in medical areas such as disease
detection and therapy.
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APPENDIX

Cell Culture Protocol
Human lung adenocarcinoma epithelial cells (A549) were purchased from ATCC and is
the only current cell line in the lab. Cells are kept in a humidified incubator at

37 °C with 5%

CO2.
The cells are cultured in Ham’s F-12K (Kaighn’s) medium supplemented with 10% Fetal
Bovine Serum (FBS) and 1% antibiotics (penicillin/streptomycin, 100 U/mL). To make complete
F-12K medium for culturing A549 cells follow the following steps:
1. Turn on the UV for the hood 10 minutes prior to working in it.
2. Spray the hood down with the 70% alcohol mixture and wipe dry with paper towel.
3. Put the following items in the hood (after warming them up in the 37 °C water bath and
then spraying with the alcohol mixture): a new bottle of incomplete F-12K (500 mL),
FBS, and the penicillin.
4. Take out 55 mL of the incomplete F-12K media using a 55 mL pipette and transfer into
a falcon tube. Label this falcon tube as “incomplete F-12K and the date”.
5. Using another 55 mL pipette, add 50 mL of FBS to the remainder of the incomplete F12K bottle.
6. Then using a 5 mL pipette, add 5 mL of penicillin to the incomplete F-12K bottle.
7. Swirl gently to ensure mixing without causing bubbles.
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8. Label the bottle as “Complete and date and ARL”. The mixture will be a red color at
first and then turn to a pink color over time.
9. Store the complete media in the fridge.
10. The FBS is stored in Dr. Zoltowski’s lab in the –80 °C freezer. Make 4 aliquots of 50
mL FBS in falcon tubes to keep in the fridge before storing it the freezer.

To passage A549 cells, follow the following steps:
1. Check the confluence of the cells. The confluence should be around 80–95% before
passaging. Otherwise, wait another day or two to allow the cells to proliferate more.
2. Turn on the UV for the hood 10 minutes prior to working in it.
3. Spray the hood down with the 70% alcohol mixture and wipe dry with paper towel.
4. Put the following items in the hood (after warming them up in the 37 °C water bath and
then spraying with the alcohol mixture): the complete F-12K media, trypsin, and PBS.
5. To start, remove the cell flask from the incubator and aspirate off the old media.
6. Wash away the dead cells by rinsing the cells with 10 mL of PBS (use a 10 mL pipette).
Then aspirate off the PBS.
7. Add 2 mL of trypsin to the flask. Move the plate around to ensure all the cells are coated
with trypsin. Then incubate for 10 minutes to allow the trypsin to break the bonds
between the cell surface and the flask.
8. Then bring the flask back to the hood and add 10 mL of complete F-12K media. Swirl
the flask slightly to make sure all the cells are in the media.
9. Using the same 10 mL pipette, draw up the entire contents of the flask back into the
pipette and transfer into a falcon tube.
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10. Tightly cap the flacon tube and put it into the centrifuge for 10 minutes at 1000 rpm.
11. Aspirate off the supernatant. Then add about 1 mL of complete media to the falcon
tube. Disperse the cells evenly throughout by using a 1000 μL pipette and pipetting up
and down multiple times.
12. Add 20 mL of complete F-12K media to a new T75 flask.
13. Add 20 μL of the cells to the flask and gently rock the flask back and forth to disperse
the cells. Check the confluence of the cells. If more cells are needed, continue to add
cells and check the confluence.
14. Lastly, label the flask with the your initials, the date, the cell line (A549), and the
passage and generation number. Store in the incubator.

The frozen cells are kept in a liquid nitrogen tank and a binder is kept nearby with the inventory
of the frozen cells. To freeze cells, follow the following steps:
1. Freezing more cells should be done after 2 or 3 passages from newly thawed cells. This
allows the cells to grow enough before freezing again.
2. The confluence should be around 80–90 % before freezing.
3. Prepare 10 mL the freezing media (10% cell-culture grade DMSO in complete media).
This will make 10 vials for freezing.
4. Follow all cell passaging steps like normal up until the centrifuge step.
5. After the centrifuge step, aspirate off the media.
6. Add 1 mL of the cell freezing media. Disperse the cells throughout the media by
pipetting up and down with a 1000 μL pipette.
7. Then add the rest of the freezing media to the falcon tube and mix.
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8. Use the cryopreservation vials to freeze the cells. Add 1 mL of the cell mixture to each
vial. Cap the vials tightly and label with the cell type, generation and passage number,
date, and initials. Parafilm the lids of the vials.
9. Put the vials in the Mr. Frosty vial container and put into the –80 °C freezer in Dr.
Zoltowski’s lab for 3 days.
10. After 3 days, transfer the vials into the liquid nitrogen container.
11. Fill out the cell inventory in the liquid nitrogen storage chart.

To thaw cells, follow the following steps:
1. Turn on the UV for at least 10 minutes prior to starting.
2. Put the complete F-12K media in the water bath and allow to reach 37 °C.
3. Check the inventory of the cells to locate the vials in the liquid nitrogen storage chart.
Pull up the cells from the liquid nitrogen tank- labeled as B. Let the liquid nitrogen drip
back into the tank before pulling it all the way out. Use the thick orange gloves when
handling the storage containers in the liquid nitrogen tank.
4. Take out 2 vials and allow them to thaw on the counter for about 5–10 minutes.
5. Spray down the hood with the 70% alcohol spray.
6. In the hood, draw up the cells from the vials and transfer into a falcon tube.
7. Add complete F-12K media to the falcon tube so the total volume is about 10 mL.
8. Centrifuge for 10 minutes at 1000 rpm.
9. Then remove the media from the falcon tube, leaving the pellet of cells.
10. Add 1 mL of complete F-12K media to the falcon tube and pipette up and down to mix.
11. Add about 20 mL of complete F-12K media to a new T75 flask.
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12. Add ALL the cells from the falcon tube into the T flask.
13. Label the flask with your initials, the date, the cell line (A549), and the passage and
generation number. (If the cell vial thawed was labeled “P2G2”, then this new flask
would be labeled “P1G3”. Store the cells in the incubator.
14. The next day, remove the media and wash the cells with 10 mL PBS. Then aspirate off
the PBS and add 20 mL of complete F-12K media. The purpose of this step is to remove
the dead cells that did not survive the freezing and thawing cycle.
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SCANNED 1H AND 13C NMR SPECTRA
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Figure S9. 13C NMR spectrum (125 MHz, CDCl3) of 10.
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